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ABSTRACT 
 
 
 
Cristina Gherghe 
 
 
 
Mechanism of Retroviral Genomic RNA Dimerization and Packaging 
(Under the direction of Kevin M. Weeks) 
 
 
Retroviral genomes are assembled from two sense-strand RNAs by non-covalent 
interactions at their 5' ends, forming a dimer. Gag, a viral polyprotein, recruits and packages 
the retroviral dimer in a nascent virion. After export from the infected cell, the virus and its 
RNA dimeric genome undergo maturation, a process that renders the virus infective. Viral 
maturation is initiated by proteolytic cleavage of Gag into a set of constituent proteins 
including nucleocapsid (NC). Gag and nucleocapsid proteins both bind the RNA dimer at 
different stages of viral development with exquisite specificity. Genomic RNA dimerization 
and packaging represent elegant, but poorly characterized, examples of molecular recognition 
and are potential targets for antiretroviral therapy. The fundamental dimerization unit for the 
Moloney murine sarcoma and leukemia gamma retroviruses (MuLV and MuSV, 
respectively) spans a 170-nt minimal dimerization active sequence (MiDAS). The MiDAS 
domain also contains sequences implicated in specific RNA dimer recognition and 
packaging. In the dimer, two self-complementary (palindromic) sequences, PAL1 and PAL2, 
form intermolecular duplexes and an SL1-SL2 (stem-loop) domain forms loop-loop base 
 iii
pairs and extensive tertiary interactions. I first develop a framework for assembly of the 
retroviral RNA dimer, by analyzing the thermal stabilities and secondary structures of 
MiDAS mutants in which PAL1, PAL2 heteroduplexes or the SL1-SL2 interactions were 
successively disrupted. The well-conserved SL1-SL2 domain makes the first and most stable 
contacts in the dimer (10 kcal/mol), while PAL1 and PAL2 heteroduplexes make much 
smaller contributions to dimer stability (0.5 to 2 kcal/mol). As an important step towards a 
common retroviral dimerization mechanism, I next demonstrate that the monomer and dimer 
MiDAS structures for two murine retroviruses (MuLV and MuSV), while not identical, are 
similarly organized. I then show that the structure of the in vitro-generated dimer robustly 
reflects the structure of the mature dimeric RNA extracted from infectious MuLV virions. In 
the genomic RNA, I identify a long-range interaction between the MiDAS domain and a 
sequence ~300 nucleotides downstream. Finally, I provide an explanation for the ability of a 
retrovirus to exclusively package only genomic RNA dimers. I characterize specific protein 
binding sites within the MiDAS domain directly inside authentic virions and confirm these 
sites in vitro. Both Gag and nucleocapsid interact specifically with the first and last 
nucleotides in UCUG sequences through precise, zinc finger-mediated, contacts. I define a 
minimal packaging signal for the retroviral RNA dimer as a tandem array of UCUG 
sequences, flanked by stable base-paired regions.  
 
 
 
 
 
 
 iv
  
 
 
 
 
 
 
 
“The reward of a thing well done is to have done it” 
− Ralph Waldo Emerson 
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Chapter 1 
 
 
 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1 Retroviruses  
Retroviruses are the causative agents of many severe diseases such as acquired 
immunodeficiency syndrome (AIDS) and T-cell leukemia in humans and several types of 
tumors in animals. Retroviruses have also been extensively developed into vectors for gene 
therapy, to introduce a desired gene into the human genome.  
Retroviral genome consists of two sense RNA strands noncovalently linked at their 5' 
ends to form a dimer1. Formation of the genomic RNA dimer is indispensable for a fully 
active virion and appears to be important for many stages of virion life cycle, including 
recombination during reverse transcription2-4 and selective packaging of genomic RNA2,5-7. 
Although retroviral dimerization has been studied intensively, both structural and 
mechanistic features of dimerization are still unclear. 
The goal of this research prospect is to elucidate the mechanism of retroviral RNA 
dimerization and packaging as fundamental processes in retroviral infection and propagation. 
This work is intended to aid retroviral drug design, genetic vector development and control, 
and to facilitate RNA biological functions and recognition mechanisms.  
 
1.2 Retroviral life cycle  
To initiate infection, a retrovirus fuses with protein receptors on the surface of the 
target cell, uncoats, and expels the genomic RNA for import into the cytoplasm (Fig. 1.1) 
along with some of the viral proteins. Among these proteins, reverse transcriptase is essential 
for further replication steps as it synthesizes cDNA using the sense RNA template. The 
cDNA is then integrated into the genome of the host cell (becoming a provirus), where it may 
remain latent until a poorly characterized signal triggers transcription of the provirus into 
2
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Figure 1.1 Retroviral life cycle. During the "early" stage of retroviral infection, the RNA 
genome is imported into the cytoplasm. This RNA is reverse transcribed and the resulting 
cDNA is integrated into the cellular genome, becoming a provirus. The "late" stage of 
infection starts with transcription of the provirus to yield a pool of full-length viral RNAs. 
The newly transcribed RNA can either be spliced and translated into viral proteins or it can 
dimerize with another RNA to yield an RNA dimer. The RNA genomic dimer is packaged by 
Gag and exported from the cell in an immature virion. A viral protease cleaves Gag in a 
subset of viral proteins, including the nucleocapsid protein. This proteolytic cleavage process 
triggers major structural rearrangements in the virus (viral maturation), among which, the 
maturation of its RNA genome to a more compact, stable, form. Only the mature form of the 
virus is infective.
Protease
Gag
Generation of 
Nucleocapsid
Cleavage 
  of Gag 
   Dimer 
maturation
Packaging
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RNA. There are two possible fates for the newly transcribed RNA: it can be spliced and used 
as mRNA, or it can remain unspliced and form a dimer with another RNA molecule, thus 
creating a genome for a new viral particle. Invariably, nascent retroviruses contain two 
identical unspliced RNA genomes linked in a dimer structure1. Strikingly, out of an 
enormous excess of cellular RNAs, two genomic RNAs selectively and exclusively interact 
to form a dimer. The elements that govern this impressive RNA-RNA selectivity are still not 
well understood. 
During retroviral assembly, the RNA dimer is recruited from the total cellular RNA 
pool and packaged in an initially immature virion8-10 by the Gag viral polyprotein11,12. After 
export from the infected cell, the viral protease cleaves Gag into its constituent proteins, 
initiating radical changes in virion architecture13,14 (viral maturation) to render it infective. 
During virion maturation, the genomic RNA dimer becomes more compact and more stable 
than the immature dimer8, process named dimer maturation. This process is facilitated by a 
product of Gag proteolytic cleavage, the nucleocapsid (NC) protein12,15.  
The mechanism by which Gag specifically recruits a full-length genomic RNA dimer 
and packages it into new virions7,16,17 is an example of outstanding protein-RNA molecular 
recognition. The fact that Gag recognizes only sequences in the RNA dimer state (not in the 
monomer) has lead to the hypothesis that the RNA recognition elements are situated within 
the dimerization domain. Indeed, in vivo studies have demonstrated that the dimerization and 
packaging regions overlap18. However, specific elements that govern the impressive Gag-
RNA dimer specificity are not well characterized.  
 
 
4
1.3 The classical RNA dimerization domain structure model 
The first indication that the retroviruses contain an RNA aggregate, rather than a 
single genome, came forty years ago when sedimentation constants measured in sucrose 
gradients proved much larger than expected for single genomic RNAs19. The dimeric nature 
of this aggregate was first demonstrated almost ten years later by electron microscopy. Partial 
denaturation of RNA dimers in formamide allowed visualization of two RNA molecules 
forming the most stable contact at their 5' end20. 
 One of the problems posed by the dimerization studies was dissecting the role of 
RNA and proteins in dimerization. In 1990, short retroviral RNAs were shown to dimerize in 
vitro in the absence of any protein21,22, at certain ionic and temperature conditions. With 
these advents, the length of the minimal dimerization domain and the contribution of distinct 
RNA domains to dimerization have started to be delineated.  
 Moloney Murine Leukemia and Sarcoma Viruses (MuLV and MuSV, respectively) 
have served as important, representative retroviral systems for studying RNA dimerization. 
Initial studies on gamma retroviral RNAs revealed that two RNA genomes interact at their 5' 
ends in a 454-nt long region named Dimer Linkage Sequence (DLS), organized as a 
collection of stem loops23 (a region of the monomeric DLS is shown in Fig. 1.2 A). The DLS 
was shown to contain two palindromic sequences, PAL124,25 and PAL226,27, capable of 
forming intermolecular duplexes (Fig. 1.2 B) between two monomer strands. Conventionally, 
the PAL2 stem loop was proposed to form the first contact between two DLS regions. At the 
3' end of the MiDAS region, a double hairpin motif, containing apical GACG tetraloops was 
found to be conserved among retroviruses28. This double stem loop domain (SL1-SL2) is 
able to form C-G Watson-Crick base pairs between two RNA monomers29 (Fig. 1.2 C). 
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Figure 1.2 Conventional secondary structure model for a representative region of the dimer 
linkage sequence and major types of interactions in the dimer. B. Heteroduplex formation 
between the PAL1 stem loops of two monomer strands. C. Loop-loop interactions formed 
between two SL1-SL2 motifs29. 
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Studies of the DLS lead to distinct, often conflicting, structural models for this region23,30, 
hindering structural comparisons between dimerization domains of different retroviruses and 
accurate mechanistic conclusions.  
 
1.4 The novel RNA dimerization domain structure model 
Correct structural models for MiDAS in the monomer and both immature and mature 
dimer states are the starting point for understanding the functions of the genomic dimer in 
retroviral biology. Our laboratory has defined a 170-nt Minimal Dimerization Active 
Structure (MiDAS)31 that contains the elements necessary for efficient RNA dimerization in 
vitro31 and in vivo, even if placed in the context of non-viral flanking RNAs7. Additionally, 
MiDAS also contains elements necessary for specific in vivo packaging of the viral dimer by 
Gag protein18.  
New structural models for the MuSV MiDAS monomer31 confirm the classical 
monomer structure for PAL1 stem loop, top of SL1, and SL2. However, PAL2 is not 
confined in a stem loop, as previously proposed, but is part of the flexible domain anchored 
by a base paired stem structure (Fig. 1.3 A). A similar, but only partly overlapping flexible 
domain exists in the dimer (Fig. 1.4 A)32, between PAL1 and PAL2 heteroduplexes. In both 
monomer and dimer states, the flexible domains can adopt distinct, but unstable, structures. 
These novel models for the MiDAS monomer and dimer structures point to a different 
dimerization mechanism, in which the flexible PAL2 sequence favors the formation of the 
dimer not by forming the first interaction in the dimer, but by limiting the amount of 
structure that needs to be melted in the initial monomer state. 
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1.5. Research overview  
Understanding the structures of the MiDAS monomer and dimer lays the foundation 
for dimerization studies and raises further important structural and mechanistic questions. 
Which interaction happens first? Which interaction confers the largest stability to the dimer 
structure? Can the in vitro dimer structure be extrapolated to the in virio structure? Does the 
in vitro dimer structure resemble the immature or the mature in virio dimer? Can the 
dimerization mechanism be extrapolated to other retroviral systems? What are the 
determinants for genomic RNA dimer packaging (by Gag) and maturation (by NC)? 
  In this work, I attempt to answer these questions (Fig. 1.5) by analyzing the 
structure of the dimerization domain in different contexts, using selective 2'-hydroxyl 
acylation analyzed by primer extension (SHAPE), a single-nucleotide resolution structural 
mapping technique invented in the Weeks laboratory33,34. SHAPE chemistry is based on the 
observation that 2'-hydroxyl positions in flexible nucleotides react preferentially with 
electrophilic reagents like N-methyl-isatoic anhydride (NMIA), to form 2'-O-ester adducts:  
 
 
 
 
 
Nucleotides tagged with 2'-O-adducts are detected as stops to reverse transcriptase in a 
subsequent primer extension reaction. Extension reactions are performed using radiolabeled 
or fluorescently-labeled DNA primers and resolved by gel and capillary electrophoresis, 
respectively.  
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This thesis focuses on: (i) developing a thermodynamic framework for gamma 
retroviral RNA dimerization (Chapter 2), (ii) drawing comparisons between the monomer 
and dimer structures of two related retroviruses, MuLV and MuSV (Chapter 3), (iii) finding 
correlations between RNA dimer structures determined in vitro and those that exist inside 
virions (Chapter 3), and (iv) analyzing Gag and NC RNA binding sites directly inside virions 
and finding a minimal RNA packaging motif recognized by Gag protein (Chapter 4). 
      
1.5.1 The SL1-SL2 domain is the primary determinant for stability of the 
gamma retroviral genomic RNA dimer. In Chapter 2, I develop a framework for assembly 
of the retroviral RNA dimer. To determine the contribution of each MiDAS element to the 
stability of the RNA dimer, I analyze MiDAS variants in which each of the PAL1, PAL2 and 
SL1-SL2 motifs was compromised. Classically, PAL2 was thought to make the first 
interaction between two monomers. Additionally, the dimer structure was considered to be 
held together by the PAL1 and PAL2 extended intermolecular duplexes, which were 
postulated to be the most stable interactions in the dimer. Contrary to this model, I 
demonstrate that interactions between SL1-SL2 domains are the first and most stable contacts 
in the dimer, contributing a large free energy increment (~10 kcal/mol). In contrast, although 
PAL1 and PAL2 intermolecular duplexes span 10 and 16 base pairs in the dimer, 
respectively, they make small contributions to the stability of the final dimer (0.5 - 2.5 
kcal/mol, roughly equal to a single base pair). These results emphasize that intermolecular 
duplex formation plays a biological role distinct from simply stabilizing the structure of the 
retroviral genomic RNA dimer. Additionally, as the sequences in the SL1-SL2 domain are 
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broadly conserved among retroviruses28, this work points to a universal retroviral RNA 
dimerization mechanism. 
 
1.5.2 Structure of the mature Moloney murine leukemia virus genomic RNA 
dimer. Part of a major goal of developing a common retroviral RNA dimerization 
mechanism is to demonstrate that the RNA dimerization domains are organized similarly in 
different viruses. My analysis focuses on the related retroviruses MuLV and MuSV, which 
differ by five nucleotides in the dimerization domain. I map the MiDAS structures of the 
monomer (Fig. 1.3 B) and dimer (Fig. 1.4 B) states for MuLV RNA and compare them with 
their corresponding structures previously determined for MuSV (Fig. 1.3 A and 1.4 A). The 
architectural features of the dimerization domains for the two viruses are conserved, 
implying a similar RNA dimerization mechanism.  
Viral maturation involves large scale morphologic changes in the newly-released viral 
particle that include conversion of the RNA dimer to a more stable, compact, mature form8. 
Genomic RNA maturation has been analyzed using RNAs extracted from virions8, whereas 
structural models for the monomer and dimer RNA are based on simplified RNAs analyzed 
in vitro31,32. I compare the structures of the final dimer generated in vitro and the mature 
dimer gently extracted from virions. I show that the in vitro dimer structure i) is biologically 
relevant and ii) corresponds to the mature RNA dimer form. The single difference between 
the two dimer structures is a long-range interaction between the MuLV MiDAS domain and a 
sequence situated ~300 nucleotides downstream that only appears in the genomic dimer. This 
interaction presumably facilitates compaction of the mature genomic RNA dimer. 
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1.5.3 Direct analysis of Gag and nucleocapsid binding sites in the dimerization 
domain of the mature Moloney murine leukemia viral RNA genome. Viral assembly 
depends on selective binding and packaging of the genomic RNA by Gag polyprotein11,12. 
From an immense pool of cellular RNAs, Gag binds the RNA dimer specifically7,16,17, 
through its C-terminal NC domain12. After export from the infected cell, viral infectivity is 
initiated by proteolytic cleavage of Gag to generate a set of proteins, including the NC 
protein13,14. To assess Gag and NC binding to the RNA dimer, I map conformational changes 
that accompany Gag and NC binding to the dimerization domain of MuLV.  
I identify specific protein binding sites in the mature RNA dimer both inside 
authentic virions and in vitro. Both Gag and NC interact specifically with the first and last 
nucleotides in UCUG sequences through precise, zinc finger-mediated, contacts. Contrary to 
the existing model that Gag binds guanosines in single stranded regions11, I show that the 
minimal packaging signal for the retroviral RNA dimer is a flexible tandem UCUG sequence 
flanked by stable base-paired regions. This structure only forms in the context of the genomic 
RNA dimer and provides an explanation for the viral propensity to package only RNA 
dimers.  
 
1.6 Perspective: RNA dimerization as a tool for medicine, genetics and biology 
Current antiretroviral drugs target the function of retroviral proteins (fusion receptors, 
reverse transcriptase, integrase and protease). However, retroviruses possess ingenious 
defense mechanisms to protect themselves from the immune system and conventional drugs. 
During a single replication cycle, a viral particle generates a large repertoire of viral 
genotypes and phenotypes in (viral quasispecies)35,36 by two strategies: first, reverse 
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transcriptase lacks a proofreading activity, introducing mutations in the proviral DNA and in 
subsequent protein products. Second, the virus is capable of complex genetic rearrangements 
between the two genomic RNA strands, yielding a vast array of progenies. The unusually 
high viral genetic variability reflects into changes in the target protein sequence and structure 
and thus in viral susceptibility to current drugs. Therefore, antiretroviral regimens use 
combinations of drugs that are designed to overwhelm the viral machinery by strongly hitting 
multiple targets at the same time. Nevertheless, using high doses of multiple drugs poses 
three main problems: amplified side effects, drug interactions and early host resistance to 
therapy.  
As a major player in the retroviral life cycle, the RNA dimerization domain sequence 
is conserved during the replication cycle of a virion and, therefore, a promising antiretroviral 
drug target. Because the SL1-SL2 domain makes the first and most stable contact in the 
genomic dimer (Chapter 2), drugs that bind and modulate this structure would greatly 
decrease the efficiency of dimerization. Moreover, as the SL1-SL2 domain is conserved28 
and the dimerization domain is similarly organized for related retroviruses (Chapter 3), new 
antiretrovirals would be beneficial for an entire class of pathogens. Additionally, the minimal 
packaging domain, the determinant of Gag-RNA binding specificity, represents a compelling 
drug target. 
A thorough understanding of the dimerization process also has applications in 
optimizing gene therapy trials. Reverse transcription of the encoding viral RNA into DNA 
that inserts in the host genome has allowed retroviruses to be used as vectors for genes of 
interest. Gene therapy has proven promising for treating diseases such as: severe combined 
immunodeficiency disorder37, cystic fibrosis38, muscular dystrophy39, and even for metastatic 
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cancer treatment40. However there are several impediments for successful gene therapies. 
High levels of recombinant retroviral vectors are needed for starting a gene transfer 
protocol41. This requirement is hindered by the mutations and deletions intentionally 
introduced into the viral genome along with the desired gene. An in depth knowledge of the 
factors that affect RNA dimerization in cis or in trans allows preserving the integrity of all 
the dimerization components and will increase the viral titers. As RNA dimerization is 
essentially an RNA-centered process, with Gag and nucleocapsid just fine-tuning an already 
developed structure (Chapter 4), the first requirement for obtaining high therapeutic viral 
titers is maintaining the intact structure of the dimerization domain. 
One other difficult shortcoming of gene therapy is generation of replication-
competent, revertant, viruses during the late phase of viral infection, when DNA is 
transcribed into RNA. This allows viral propagation in vivo, thus causing an iatrogenic 
infection. Interfering with the tandem UCUG packaging motif while preserving the rest of 
the dimerization domain would diminish packaging by Gag (Chapter 4) by arresting the 
retrovirus in the original host cell. 
 The exquisite specificity of retroviral RNA dimerization and packaging offers 
insights into the biology of some of the smallest, but most complex pathogens. The next 
frontiers in understanding retroviral intricate mechanisms of infection would be: to determine 
the rates and the order of interaction of all the elements in the dimerization domain and to be 
able to structurally characterize the genomic dimer in vivo, in all its intra- and extra-cellular 
stages.   
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Chapter 2 
 
 
 
 
The SL1-SL2 (Stem-Loop) Domain Is the Primary 
Determinant for Stability of the Gamma Retroviral Genomic 
RNA Dimer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1 The retroviral RNA genomic dimer  
Retroviruses carry their genetic information in the form of RNA and replicate through 
a DNA intermediate1. The retroviral genome consists of two non-covalently linked sense 
strand RNAs, forming a dimer2-4. Formation of the genomic RNA dimer appears to be 
important for key stages of the retroviral replication cycle including selective packaging of 
genomic RNA4-6, reverse transcription and recombination7-10. 
 
2.1.1 The minimal dimerization active structure (MiDAS). Although a retroviral 
RNA genome forms multiple contacts between its constituent monomers, the most stable 
point of contact is situated at the 5' end of the RNA11-14. Our laboratory has defined and 
structurally characterized a minimal dimerization active sequence (MiDAS) of 170 
nucleotides for a representative gamma retrovirus, the Moloney murine sarcoma virus 
(MuSV), as the major 5' dimerization motif15,16 (Fig. 2.1). The MiDAS is a structurally 
independent domain that dimerizes efficiently to yield homogeneous monomer and dimer 
populations in vitro.  The MiDAS RNA dimerizes under biologically relevant conditions of 
both temperature and ionic environment, in the absence of proteins. Moreover, RNAs 
spanning sequences closely related to the MiDAS are sufficient to mediate RNA dimerization 
and encapsidation in vivo when inserted into non-viral mRNAs3,17. Thus, the MiDAS domain 
is an important system for studying retroviral RNA dimerization as it contains all of the RNA 
sequence elements required for the high selectivity and affinity of this process both in vitro 
and in vivo. 
 
2.1.2 Key RNA dimerization elements in MiDAS. Structures of the MiDAS domain 
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Figure 2.1 Secondary structures and conformational changes that accompany dimerization of 
the MiDAS domain for the MuSV gamma retrovirus. Major interaction sites (PAL1, PAL2 
and the SL1-SL2 tetraloops) are emphasized in color. The anchoring helix and the 
nucleotides that yield a four base pair extension of SL1 are emphasized with shaded and 
black boxes, respectively. Multiple conventions are in use for the PAL1, PAL2, SL1 and SL2 
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for MuSV in the monomeric starting state and in the final dimer state have been mapped at 
single nucleotide resolution using selective 2'-hydroxyl acylation and primer extension 
(SHAPE)15,16. Taken together with extensive prior work18-26, these structural studies 
emphasize that there are three major components of the retroviral dimer: two self-
complementary (palindromic) sequences, termed PAL1 and PAL2, plus a double stem-loop 
(SL1-SL2) domain (Fig. 2.1). The two stem-loops, SL1 and SL2, contain conserved GACG 
tetraloops18 and function together as an independent domain24,25,27,28. 
The existence of self-complementary sequences with the potential to form 
intermolecular duplexes is broadly conserved among retroviruses18,21.  Similarly, stable stem 
loop motifs, terminating in GACG tetraloops, are prominent features for at least two 
retroviral genera, the gamma retroviruses18 and the non-primate lentiviruses29.  
Understanding the relative structure contributions of self-complementary and GACG stem-
loop domains is essential to develop models for the broad organizing principles of RNA 
genome structure the ability of retroviruses to function as simple diploid entities in biology. 
Significant conformational changes occur in each of the three PAL1, PAL2 and SL1-
SL2 domain structural building blocks during dimerization15,16,19-22,27 (Fig. 2.1).  PAL1 
resides in a stem-loop structure in the monomer state and forms an extended intermolecular 
duplex involving both genomic RNA strands in the dimer (green sequences, Fig. 2.1). PAL2 
is relatively unstructured in the MiDAS monomer and lies in a flexible domain that is 
connected to the rest of the RNA via a stable anchoring helix (shaded box, Fig. 2.1 A)15. 
Upon dimerization, the unstructured PAL2 sequences from two monomers also form an 
extended intermolecular duplex (red sequences, Fig. 2.1). As the PAL2 intermolecular 
duplex forms, the anchoring helix characteristic of the monomer state melts (shaded boxes, 
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Fig. 2.1 B)16. 
At the 3' end of the MiDAS, SL1 and SL2 form cross-strand loop-loop interactions 
involving conventional G-C base pairs and additional non-canonical interactions25 with SL2' 
and SL1' sequences, respectively, from the second RNA strand (orange sequences, Fig. 2.1). 
During dimerization, SL1 also extends by four base pairs (black box, Fig. 2.1 B)27. When this 
conformational change occurs, the SL1-SL2 domain forms a compactly folded and high 
affinity tertiary structure domain27. Formation of the PAL2 intermolecular duplex and 
extension of SL1 in the dimer state both require disruption of the anchoring helix. Thus, 
PAL2 and SL1-SL2 domain interactions are potentially coupled during dimerization. 
 
2.2 Evaluating the role of MiDAS structures to retroviral dimer stability  
I analyze the contribution of each of these key structural features to the stability of the 
MuSV genomic RNA dimer. In the context of the MiDAS domain, the SL1-SL2 domain 
interaction makes the largest contribution to overall thermodynamic stability in the dimer. 
PAL1 and PAL2 form 10 and 16 base pair duplexes in the dimer and, as isolated structural 
elements, would be expected to have large thermodynamic stabilities of up to –15 kcal/mol. 
Unanticipatedly, the net thermodynamic increment for forming either the PAL1 or PAL2 
intermolecular duplex in the dimer is small. I infer that the free energy released upon 
formation of either extended duplex in the dimer is almost exactly balanced by the energetic 
cost to break preexisting interactions in the starting monomer structure. These data indicate 
that the highly conserved ability to form intermolecular duplexes in retroviral RNA genomes 
may be more important for retroviral processes such as modulating protein binding sites or 
regulating dimerization kinetics than simply stabilizing the dimer state. 
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 2.3 Results 
2.3.1 Strategy. To quantify the energetic contribution of each element of the MiDAS 
RNA to stability of the retroviral dimer, I constructed mutants designed to compromise 
precisely each of the three primary contributors to dimerization: PAL1, PAL2 and the SL1-
SL2 domain (Fig. 2.2). The ability of PAL1 to form an intermolecular duplex in the dimer 
was abolished by stabilizing the PAL1 stem-loop in its monomer form to make the PAL1Stb 
mutant (Fig. 2.2 A). PAL2 was compromised by a 12-nucleotide deletion in the PAL2Del 
mutant (dashed blue line, Fig. 2.2 B). This deletion completely abrogates PAL2 
intermolecular duplex formation, but does not cause significant structural changes in other 
parts of the MiDAS RNA15. I also constructed a double PAL1Stb-PAL2Del double mutant, 
Stb-Del, that eliminates both PAL1 and PAL2 duplexes in the dimer (Fig. 2.2 C).  
Two SL1-SL2 domains form an extensive tertiary interface mediated by loop-loop 
interactions involving the GACG sequences in the apical loops25 and by interdigitated 
interactions between closely packed U-shaped SL1-SL2 motifs27. No simple, compact, 
mutation can completely disrupt this tertiary interface; however, we selectively disrupted the 
loop-loop component of the SL1-SL2 domain tertiary structure by converting the conserved 
GACG sequence in the apical tetraloops to GAAA (AA/AA mutant; blue sequences, Fig. 2.2 
D). The GAAA sequences form a stable local loop structure, but cannot form strong cross-
strand loop-loop interactions27. 
 
2.3.2 Dimerization affinities for native and mutant MiDAS RNAs. An important 
feature of the MiDAS domain is that dimerization does not require extreme temperature or 
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solution conditions.  Dimerization proceeds efficiently at 37 °C and at roughly physiological 
ionic strength (200 mM potassium acetate, 5 mM MgCl2, pH 7.5). This well behaved 
dimerization activity appears to reflect that inhibitory RNA sequences are absent in the 
MiDAS domain. Both native and mutant RNAs form homogeneous monomer and dimer 
species as judged by non-denaturing gel electrophoresis (Fig. 2.3).   
Exploratory work showed that RNA dimers in which either the PAL1 or PAL2 
intermolecular duplex has formed can be detected by non-denaturing gel electrophoresis, 
both in the presence and absence of Mg2+. Dimerization at the SL1-SL2 domain specifically 
requires the presence of Mg2+ in the gel running buffer to be detected during electrophoresis. 
Thus, dimerization for all RNA constructs was visualized in both Mg2+-free and Mg2+-
containing gels (Figs. 2.3 A,B). Dimerization reactions were performed as a function of RNA 
concentration and allowed to equilibrate for 2 or 8 hours. Apparent dimerization dissociation 
constants (Kdimer) decrease by 3-fold or less when the equilibration period is extended from 2 
to 8 hours. I therefore take the 8-hour value as a good approximation for fully equilibrated 
retroviral RNA dimers. 
The native MiDAS RNA forms a very high affinity dimer, independent of the 
presence of Mg2+ in the gel. Kdimer values are 0.39 and 0.22 nM, as visualized in gels run in 
the absence and presence of Mg2+, respectively (open and closed circles, Figs. 2.3 C,D).  
I then evaluated the thermodynamic contribution of the SL1-SL2 domain to dimer 
formation using the AA/AA mutant in which native loop-loop interactions are disrupted.  
Dimerization affinities are similar, independent of whether Mg2+ is present in the gel. 
However, dimerization is weakened by ~100-fold relative to the native sequence (Kdimer = 20 
nM; open and closed squares in Fig. 2.3). Thus, the SL1-SL2 domain is a significant 
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contributor to the stability of the dimer state. 
In contrast, the PAL1Stb and PAL2Del RNA variants, which eliminate the ability to 
form either PAL1 or PAL2, dimerize with affinities that are within 2.5-fold of that for the 
wild type (triangles and inverted triangles, Fig. 2.3). These data indicate that formation of 
either the PAL1 or PAL2 intermolecular duplex makes a very small contribution to the 
stability of the dimer if the SL1-SL2 domain is present. 
I next evaluated the dimerization activity of the Stb-Del mutant, in which both PAL1 
and PAL2 are compromised. This RNA is only capable of dimerizing by forming interactions 
in the SL1-SL2 domain, including via cross-strand loop-loop base pairs at the GACG 
tetraloops (see Fig. 2.1). Dimer stability is strongly dependent on whether Mg2+ is present 
during non-denaturing gel electrophoresis (Stb-Del panels, Figs. 2.3 A,B). Formation of a 
dimer species is barely detectable in gels run in the absence of Mg2+ (apparent Kdimer ~4.2 
µM); whereas, stable dimer formation is readily detected in Mg2+-containing gels and is 
characterized by a Kdimer of 25 nM.  
These results demonstrate that two SL1-SL2 domains form a high affinity interaction 
that is strongly dependent on the presence of Mg2+. In the presence of the stable Mg2+-
mediated SL1-SL2 domain interaction, PAL1 and PAL2 each then make small additional 
contributions to dimer stability. 
 
2.3.3 Structural analysis of dimers. I explored the specific structural differences in 
the dimers formed by the PAL1Stb, PAL2Del and Stb-Del mutants using single nucleotide-
resolution RNA SHAPE analysis30,31. In the SHAPE approach, an RNA is treated with a 
strongly electrophilic reagent, N-methylisatoic anhydride (NMIA), that reacts preferentially 
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with 2'-hydroxyl groups in conformationally flexible nucleotides. Flexible nucleotides react 
to form 2'-O-ester adducts, which are then detected as stops to reverse transcriptase-mediated 
primer extension. 
The secondary structure of the MiDAS region in the dimer state was recently 
established by SHAPE16. I confirmed the secondary structure of our MiDAS dimer by 
subjecting the native dimer RNA to 2'-O-esterfication and detecting cDNA products in a 
sequencing gel (Fig. 2.4 A). Absolute SHAPE reactivities were calculated by subtracting 
background band intensities observed for reactions omitting NMIA from those obtained in 
the presence of the reagent (Fig. 2.4 B). Local nucleotide flexibility information was 
obtained for almost every position in the MiDAS RNA.  
The nucleotides comprising the PAL1 and PAL2 intermolecular duplexes are 
uniformly unreactive towards SHAPE chemistry (Fig. 2.4 C). SL1 and SL2 form stable stem-
loop structures connected by a flexible two-nucleotide linker (nts 353-354). The PAL1, 
PAL2 and SL1-SL2 domain structures are then linked two flexible linker regions (nts 220-
282 and 299-309; Fig. 2.4 C). SHAPE analysis thus strongly supports the secondary structure 
model for the dimer state shown in Fig. 2.4 C. 
 
2.3.4 SHAPE analysis of MiDAS mutants. Absolute nucleotide reactivities were 
also obtained for the PAL1Stb, PAL2Del and Stb-Del mutants using SHAPE chemistry. 
Structural differences both at single nucleotides and over larger RNA sequences between 
each mutant and the native sequence in the dimer state can be evaluated in a straightforward 
way using reactivity histograms (Fig. 2.5). SHAPE reactivity for the native sequence is gray 
and reactivities for the mutants are shown in color. Higher and lower reactivities for a mutant 
 31
BA
Not analyzed
Background stops
Reactivity
moderate  
high 
C
PAL2PAL1 SL1 SL2
R
ea
ct
iv
ity
S
H
A
P
E
5'
3'
320
340
360
300
280
240
220
205
374355352310
PAL1 PAL2
SL1
SL2
221
254
303
314
319
340
354
220 240 260 280 300 320 340 360
low 
5' 3'
290
270
260
250
280
313
310
303
298
318
NMIA
PA
L2
 e
xt
en
de
d 
   
   
du
pl
ex
S
L1
+Seq
moderate 
high 
5'
3'
Figure 2.4 SHAPE analysis of the native MiDAS RNA in the dimer state. A. Primer 
extension reactions resolved on a sequencing gel for RNAs treated in the presence (+) or 
absence (-) of the structure-selective reagent, NMIA. G, guanosine sequencing lane; 
sequence is offset by one nucleotide relative to NMIA lanes, numbering refers to NMIA 
lanes. B. Histogram of absolute SHAPE reactivities, minus background, as a function of 
nucleotide position. C. Superposition of SHAPE information on a secondary structure model 
for the MiDAS RNA dimer. For clarity, only one of the two strands in the dimer is annotated.
32
305
314
A
B
C Stb-Del
PAL2Del
PAL1Stb
220 240 260 280 300 320 340 360
Seq
219 283 298 316 355310
221
231 249
266
287
303
348
351
221
239
249
314
05
314
305
317
317
5' 3'
348 352
303
PAL2PAL1 SL1 SL2
Figure 2.5 Structural differences between native and mutant MiDAS RNAs analyzed by 
SHAPE chemistry. In each histogram, mutant and native RNAs are shown by colored and 
gray lines, respectively. Stars indicate a small number of positions that could not be analyzed 
due to strong SHAPE chemistry-independent stops to primer extension.
33
at a given position indicate that the mutant sequence is more flexible or more constrained, 
respectively, relative to wild type. 
 The reactivity profile for the PAL1Stb variant superimposes very closely with that 
for the wild type sequence over nearly the entire length of the MiDAS domain (compare red 
and gray lines, Fig. 2.5 A). The most significant difference is the reduced reactivity of nt 221 
in the PAL1 stem at the 5' end of the RNA, indicating that this position is more constrained 
in the PAL1Stb mutant. The observed low reactivity at nucleotide 221 reflects the stabilizing 
effect of the mutation introduced at this position that stabilizes the PAL1 stem-loop in the 
monomer-like conformation (Fig. 2.2 A). The primer extension reaction also records the 
increased stability of the PAL1 stem-loop in an indirect way, because the stabilized PAL1 
structure yields a prominent stop to primer extension by the reverse transcriptase enzyme (nts 
223-229, dashed line in Fig. 2.5 A). Thus, SHAPE analysis indicates that the PAL1Stb 
mutant folds to a dimer structure that is very similar to that of the native sequence, except 
that PAL1 remains in its monomeric conformation, embedded in a stem-loop (Fig. 2.6 A). 
The PAL2Del mutation was shown previously to induce only relatively minor 
changes to the structure of the monomer state.  The PAL2Del is compatible with the 
monomer conformation because PAL2 lies in the middle of a large flexible domain (Fig. 2.1 
A).  In contrast, the PAL2Del mutation introduces many changes to the structure of the final 
dimer (compare green and gray histograms, Fig. 2.5 B). The most important structural 
differences lie in three distinct regions in the PAL2Del mutant RNA.  Positions spanning nts 
231-249 and 305-314 include the anchoring helix and are much less reactive in the mutant 
than in the native dimer. Second, nucleotides 317-318 and 351 are more reactive in the 
mutant, consistent with a model in which SL1 remains in the shorter, monomer-like 
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conformation for this stem-loop (see Fig. 2.1 A). Finally, nucleotides 265-268, 287-288 and 
303 in the PAL2 sequence and in other parts of the flexible domain are more reactive in the 
mutant, consistent with failure to form the PAL2 helix. Together, the comparative SHAPE 
reactivity information is consistent with a secondary structure model for the PAL2Del dimer 
in which the PAL1, but not the PAL2 intermolecular duplex forms (Fig. 2.6 B). An important 
feature of the PAL2Del variant in the dimer state is that the anchoring helix (nts 231-
241/305-315) does not melt and the SL1-SL2 domain remains in the monomer-like 
conformation (compare Figs. 2.4 C and 2.6 B).  
The Stb-Del double mutant dimer has a SHAPE reactivity profile broadly consistent 
with a simple combination of the reactivity profiles for both the PAL1Stb and PAL2Del 
mutants (in orange, Fig. 2.5 C). Similar to the PAL1Stb mutant, the double mutant shows 
decreased reactivity at the 5' end of the RNA (nts 220-223), suggesting that PAL1 remains in 
its monomeric stem-loop conformation. Again, the stabilized PAL1 stem-loop yields a strong 
stop for primer extension (dashed line at nts 224-229, Fig. 2.5 C). The Stb-Del dimer also 
contains features analogous to those seen with the PAL2Del mutant. Nucleotides 239-249 
and most nucleotides spanning 305-314 are less reactive, indicating that the anchoring duplex 
does not melt in this mutant dimer structure. Nucleotides 317 and 347-349 are more reactive 
toward NMIA, supporting the short monomer-like conformation for SL1. The reactivity 
profile of this mutant is consistent with a secondary structure model in which most of the 
RNA remains in a monomer-like conformation. Two Stb-Del mutant monomers therefore 
dimerize (see Fig. 2.3 B) primarily through loop-loop contacts in the SL1-SL2 domain, 
without support from either the PAL1 or PAL2 intermolecular duplexes (Fig. 2.6 C). 
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2.4 Discussion  
2.4.1 A thermodynamic framework for gamma retroviral RNA dimerization. 
Three pieces of information allow me to define a thermodynamic framework for gamma 
retroviral RNA dimerization under near-physiological conditions of temperature and ionic 
environment.  First, I have quantified the thermodynamic contribution of each of the PAL1, 
PAL2, and SL1-SL2 interactions to overall dimer stability. Eliminating the ability of either 
the PAL1 or PAL2 sequences to form intermolecular duplexes does not significantly reduce 
the stability of the genomic RNA dimer (Fig. 2.3).  An independent analysis also emphasized 
that PAL2 makes a small contribution of dimer stability 32. The most significant determinant 
of dimer stability is the SL1-SL2 domain.  Disrupting the cross-strand loop-loop base pairing 
component of the SL1-SL2 domain reduces dimerization affinity by 100-fold.  
Second, structural analysis of native and mutant dimers at single nucleotide resolution 
using RNA SHAPE chemistry indicates that folding of PAL2 and the SL1-SL2 domain are 
interdependent (Figs. 2.4-2.6). Both formation of the PAL2 intermolecular duplex and 
extension of the SL1 helix to achieve the final dimer conformation require disruption of the 
anchoring helix.   
Third, our lab has previously measured dimerization affinities for the isolated SL1-
SL2 domain in both monomer and dimer conformations (Fig. 2.7). By comparing 
dimerization affinities for the isolated SL1-SL2 domain with those for the complete MiDAS 
motif, I can quantify the additional energetic increment, if any, resulting from formation of 
the PAL1 and PAL2 intermolecular duplexes.  
I describe each step in the thermodynamic pathway for gamma retroviral RNA 
dimerization from two perspectives: energetically, in terms of the microscopic or incremental 
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dimerization dissociation constants, and structurally, as a nucleotide-resolution secondary 
structure for each dimer intermediate. My thermodynamic model for dimerization comprises 
three major steps: the high affinity and bimolecular association of two monomers through 
cross-strand loop-loop interactions in the SL1-SL2 domain plus two low affinity 
unimolecular rearrangements to form the PAL1 and PAL2 intermolecular duplexes (Fig. 
2.8). 
 
 2.4.2 The SL1-SL2 domain significantly stabilizes the MiDAS dimer. Structural 
analysis indicates that the PAL1Stb and PAL2Del mutants precisely affect the targeted 
structural element and that neither mutation causes unexpected non-native interactions to 
form (Fig. 2.6). Therefore, the loop-loop interaction in the SL1-SL2 domain in the first step 
can be estimated to be comparable to the dimerization affinity for the Stb-Del mutant because 
the SL1-SL2 interaction is the only possible dimerization motif remaining in this mutant 
(orange labels, Fig. 2.8). The SL1-SL2 dimerization interaction is strongly modulated by 
Mg2+.  In the presence of the divalent ion, the dimerization constant is 25 nM (Fig. 2.3 D).  
This value is similar to the dimerization constant measured previously for the isolated SL1-
SL2 domain, also in the presence of Mg2+ (Fig. 2.7 A)27. Thus, either as an independent 
motif or in the context of the MiDAS, the SL1-SL2 domain contributes a large free energy 
increment to dimerization, corresponding to –10 kcal/mol (Fig. 2.8). 
 
2.4.3 PAL1 and PAL2 make small contributions to dimer stability. Once formed, 
the initial SL1-SL2 dimer can undergo subsequent conformational changes via two 
unimolecular rearrangements: formation of either the PAL1 or PAL2 intermolecular 
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duplexes. Overall Kdimer values for formation of the PAL1, PAL2, or final dimer are taken to 
be the dimerization affinities for the PAL2Del, PAL1Stb, and native sequence dimers, 
respectively. I can then calculate the incremental, or step-wise, contribution of forming the 
PAL1 or PAL2 intermolecular duplexes relative to the SL1-SL2 dimer using the relationship:  
 
overall Kdimer = (product of Kx values for pathway). 
 
Formation of the PAL1 or PAL2 intermolecular duplex from the SL1-SL2 dimer state is 
characterized by similar incremental dissociation constants of 0.021 and 0.018, respectively 
(K2 and K2', Fig. 2.8). These microscopic constants correspond to stabilizing free energy 
increments of –2 kcal/mol. The net energetic contribution for forming either intermolecular 
duplex is therefore remarkably small, corresponding roughly to that of a single base pair33.  
The net thermodynamic increment for forming the PAL1 or PAL2 intermolecular 
duplex, as an isolated structural element, can be calculated as the difference in free energy of 
the monomer and dimer states (Table 2.1). The PAL1 hairpin in the monomer and its 
intermolecular duplex forms have calculated34 free energies of –4.6 and –14.1 kcal/mol:  
dimerization at PAL1 therefore could, in principle, contribute –9.5 kcal/mol to the stability of 
the dimer. PAL2 lies within a larger flexible domain that is well modeled as three 
interconverting constituent structures15.  The net increment for forming the PAL2 duplex in 
the dimer from these three structures is approximately –9.3 kcal/mol. 
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The calculated contribution for formation of either the PAL1 or PAL2 intermolecular 
duplexes as isolated secondary structure elements relative to their structures in the monomer 
state are therefore each greater than –9 kcal/mol based on nearest neighbor free energy 
parameters33,34. There exists a large discrepancy between these calculated values and the 
measured increment (Fig. 2.3) of only –2 kcal/mol. 
Once either the PAL1 or PAL2 intermolecular duplex forms initially, formation of the 
second intermolecular duplex makes an even more modest contribution to dimer stability. K3 
and K3' are 0.49 and 0.42 for PAL1 and PAL2 intermolecular duplex formation, respectively 
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(Fig. 2.8). The corresponding free energy increment is –0.5 kcal/mol. Again, this increment 
is much smaller than that expected for formation of isolated PAL1 and PAL2 duplexes.  In 
the context of the retroviral MiDAS RNA, formation of these new base pairing interactions 
must nearly balance disruption of favorable interactions in the monomer state. 
 
 2.4.4 PAL1 and the SL1-SL2 domain interactions are structurally coupled. Two 
of the major dimerization steps involve independent interactions between autonomous 
secondary structural elements. In the first step, the SHAPE reactivity profile for the Stb-Del 
mutant supports a model in which the structure of the initial SL1-SL2 dimer strongly 
resembles that of the starting monomer state (compare Figs. 2.1 A and 2.6 C). Moreover, the 
dimerization dissociation constant for a truncated RNA in the monomer-like state spanning 
just the SL1-SL2 domain is 11 nM (Fig. 2.7 A)27 or within 2.3-fold of our measurements of 
the SL1-SL2 dimer in the context of the intact MiDAS RNA (corresponding to the Stb-Del 
mutant). Similar binding constants provide independent support for the model that SL1-SL2 
domain interactions are stable and form independently of other interactions in the dimer.  
Similarly, SHAPE analysis of the PAL1 dimer intermediate (illustrated by the 
PAL2Del mutant) indicates that PAL1 forms without affecting other elements of the 
structure. Specifically, the anchoring helix does not melt, PAL2 still lies in the flexible 
domain, and SL1 remains in a monomer-like conformation (see PAL1 dimer, Fig. 2.8). This 
suggests that PAL1 duplex formation does not involve significant rearrangements of other 
parts of the MiDAS RNA. 
 In contrast, SHAPE analysis of the PAL2 dimer (quantified as the PAL1Stb mutant) 
indicates that PAL2 intermolecular duplex formation is coupled to two other processes: 
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melting of the anchoring helix and elongation of SL1 by four base-pairs to form a structure 
similar to that found in the final dimer state (see PAL2 dimer, Fig. 2.8). PAL2 intermolecular 
duplex formation is, therefore, not structurally autonomous, as is PAL1 dimerization. 
Extension of SL1 by four base pairs yields a distinctive SL1-SL2 domain dimer complex 
whose affinity has been measured independently to be 0.3 nM (Fig. 2.7 B). 
 Thus, favorable change in the dimerization dissociation constant for formation of the 
PAL2 dimer also reflects the contribution due to the change in conformation of the SL1-SL2 
domain (black box, Fig. 2.8). Dimerization dissociation constants for the SL1-SL2 domain 
(in the final dimer conformation; Fig. 2.7 B) and for the final, intact MiDAS dimer (Fig. 2.8) 
are identical, within error. The energetic contribution for base pairing in PAL2 is likely 
therefore even smaller than the observed –2 kcal/mol increment. Instead, formation of PAL2 
is linked to extension of SL1 and formation of a high affinity state in the SL1-SL2 domain. 
 
 2.4.5 Implications for retroviral biology. Extensive prior work has emphasized that 
the ability to form extended intermolecular duplexes, like PAL1 and PAL2, is a conserved 
feature of retroviral genomic dimerization domains5,6,18,21,35. Similarly, formation of stable 
stem-loop structures at SL1 and SL2 is a structurally conserved feature of the gamma 
retroviruses18,21,22 and these structures are important for RNA encapsidation24, viral 
infectivity28, and dimer formation3 in vivo. Heterologous RNAs carrying just the SL1-SL2 
domain are sufficient to enable packaging of retroviral RNAs into virions3,28. Structurally, 
RNAs carrying the SL1-SL2 domain form weak, but detectable, 'pre-immature' dimers3. 
However, RNAs spanning only the SL1-SL2 region do not encompass the sequences 
adequate for highly stringent dimerization in vitro15, or for optimal infectivity3,17 and Gag 
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protein binding36 in vivo. I reconcile this diverse information by proposing that the SL1-SL2 
domain is the primary determinant for dimer stability. The highly conserved ability of 
retroviral dimerization domains to form intermolecular duplexes then functions to facilitate 
other processes of the replication cycle such as enhancing the packaging of retroviral 
genomic RNA into nascent virions, modulating recognition by the viral gag or nucleocapsid 
proteins, or regulating viral maturation. 
 
2.5 Experimental procedures 
2.5.1 Retroviral RNA constructs. DNA templates for in vitro transcription of the 
native and mutant MiDAS RNA constructs (PAL1Stb, PAL2Del, Stb-Del, AA/AA) were 
generated by PCR from the pLNBS37 plasmid or from synthetic oligonucleotide (Midland) 
templates.  RNA constructs were generated by T7 RNA polymerase-mediated transcription 
[200 µL, 37 °C, 6 h; containing 80 mM HEPES (pH 7.5), 40 mM dithiothreitol (DTT), 
0.01% (v/v) Triton X-100, 2 mM spermidine, 20 mM MgCl2, 2 mM each nucleoside 
triphosphate, ~10 µg PCR-generated template, 200 U SUPERase-In (Ambion), and 0.07 
mg/ml polymerase].  Internally labeled RNAs were generated using 25 µCi α-[32P]ATP and 
0.5 mM unlabeled ATP. RNAs were purified by denaturing gel electrophoresis [8% (w/v) 
polyacrylamide, 7 M urea]; excised from the gel; eluted overnight [into 0.5 M sodium acetate 
(pH 6.0), 1 mM EDTA; 4 °C]; concentrated by ethanol precipitation; and stored in TE [10 
mM TRIS (pH 7.5), 1 mM EDTA] at -20 °C.  
 
2.5.2 Equilibrium dimerization affinities. All dimerization reactions were 
performed at 37 °C and under an approximately physiological ion environment (200 mM 
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potassium acetate, 5 mM MgCl2, pH 7.5). Internally [32P]-labeled RNA (0.05 nM) was 
combined with the identical unlabeled RNA (at 0.1-300 nM) in 6.4 µL. RNAs were 
denatured at 90 °C, snap-cooled on ice for 30 sec, treated with 3.2 µL 5× dimer buffer [250 
mM HEPES (pH 7.5), 1 M potassium acetate (pH 7.5), 25 mM MgCl2]15 and 6.4 µL loading 
dye (30% glycerol, 0.01% xylene cyanol and bromophenol blue), and incubated at 37 °C for 
either 2 or 8 hrs. Monomer and dimer forms were resolved on non-denaturing gels (8% 
polyacrylamide, 1× TBE) run at a gel temperature of 25 °C (1 h at 7 W).  RNAs were also 
resolved in gel and running buffers containing 5 mM MgCl2.  Gels were pre-run for 20 min 
prior to loading and the running buffer was re-equilibrated every 10 min to maintain uniform 
ion concentrations. Monomer and dimer species were visualized by phosphorimaging and the 
dimerization dissociation constant (Kdimer) was obtained by fitting to: fraction RNA dimer = 
  
A
4CT
(Kdimer + 4CT ) − Kdimer 2 + 8KdimerCT⎡ ⎣ ⎢ 
⎤ 
⎦ ⎥ , where A is the fraction dimer at saturating RNA 
concentrations and CT is the total concentration of RNA. 
 
2.5.3 SHAPE analysis of native and mutant dimers. Selective 2'-hydroxyl 
acylation analyzed by primer extension (SHAPE) experiments were performed on native or 
mutant MiDAS RNAs that contained a 3' non-viral RNA cassette that provides an efficient 
DNA primer binding site30, linked to the MiDAS RNA via an AAAU linker. Control 
experiments showed that introduction of the 3' cassette had no effect on dimerization 
affinities. The MiDAS RNA construct (9 pmol) was heated at 90 °C for 3 min in 2.7 µL 
water, cooled on ice, treated with 1.8 µL 5× dimerization buffer at 37 °C for 2 h.  The RNA 
solution was then treated with 1 µL  NMIA (100 mM in anhydrous DMSO), allowed to react 
for 45 min (~ 4 half lives)30,31. 
 46
2.5.4 Primer extension. DNA primers were complementary to the 3' end of the RNA 
structure cassette (5'-GAA CCG GAC CGA AGC CCG-3') or to SL1 (5'-CAG AAC TCG 
TCA GTT CCA CCA-3')15.  NMIA-modified RNA (2 µL, 1.8 pmol) was annealed to a 5'-
[32P]-labeled DNA primer (1 µL, 1 pmol) in 12 µL total volume and incubated at 60 °C (6 
min) and 35 °C (10 min).  Reverse transcription buffer [7 µL; 143 mM Tris acetate (pH 8.4), 
214 mM potassium acetate, 7.14 mM MgCl2, 1.43 mM each dNTP, 14.3 mM DTT] was 
added and subsequent primer extension steps were performed as described15, using 
ThermoScript Reverse Transcriptase (Invitrogen) at 50 °C. cDNA fragments were resolved 
on a series of 14% (w/v) polyacrylamide gels to achieve nucleotide resolution throughout the 
analyzed region. Band intensities were quantified using SAFA38. SHAPE reactivity data for 
the mutants were normalized to that of the native MiDAS using nt 314 for PAL1Stb and nt 
319 for the PAL2Del and Stb-Del mutants. 
 
2.5.5 Free energy calculations. RNAstructure34 was used to estimate the change in 
free energy associated with formation of the PAL1 and PAL2 intermolecular duplexes 
relative to the structures these sequences form in the monomeric initial state (illustrated in 
Table 2.1).   
Structures for PAL1 and PAL2 in the monomer state were obtained using strong and 
moderate SHAPE reactivities to constrain single stranded nucleotides15. PAL1 stability was 
calculated for nts 205–227. PAL2 stability was estimated for nts 244-299, as the mean 
folding free energy for three postulated15 interconverting structures in the 231-315 domain 
and subtracting the free energy of the anchoring duplex (nts 231-243/300-315). Stabilities for 
the PAL1 and PAL2 intermolecular duplexes in the dimer state were estimated using the 
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bimolecular folding mode in RNAstructure34. 
 
2.5.6 Incremental dissociation constants for individual dimerization steps. For 
the dimerization step involving SL1-SL2 domain interactions, the dimerization constant K1 
was measured directly as the affinity of the Stb-Del mutant. For steps involving SL1-SL2 
interactions plus either PAL1 or PAL2 formation, K2 and K2' were calculated from Kdimer for 
the PAL2Del and PAL1Stb mutants, respectively, as Kdimer = K1K2. For the third step, K3 and 
K3' were calculated from Kdimer for dimerization of the native MiDAS, Kdimer = K1K2K3. Free 
energies for each dimerization step were calculated as ∆G = –RT ln(1/Kx) at 37 °C. 
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Chapter 3 
 
 
 
 
Structure of the Mature Moloney Murine Leukemia Virus 
Genomic RNA Dimer 
 
 
 
 
 
 
 
 
3.1 Introduction 
Retroviruses carry their genomes in the form of two sense-strand RNAs, non-
covalently linked at their 5' ends1-5. Packaging of RNA genomes into new virions is a highly 
specific process, even in the presence of an enormous background of cellular RNAs4,6,7. This 
packaging function is carried out by the Gag protein8,9, which recognizes RNA sequences 
that also overlap with the RNA dimerization domain4. These observations are consistent with 
a model in which sequences that direct specific packaging of retroviral genomes into new 
virions are recognized by Gag only if presented in the context of the dimeric RNA structure. 
By specifically interacting with the dimeric state, the Gag-dimer interaction represents an 
elegant and direct mechanism by which exactly two genomic RNAs are packaged into each 
nascent virion.  
 Packaging of a genomic RNA dimer initially occurs in the context of an immature 
and non-infectious viral particle3,10,11. After the immature viral particle is released from the 
host cell, the virus undergoes extensive morphological changes to form the mature and 
infectious virion12. Viral maturation is initiated by cleavage of the Gag polyprotein to yield a 
set of smaller viral proteins12,13 and also involves changes to the structure of the RNA dimer 
linkage region. The dimer appears to be more compact and, for many retroviruses, more 
thermostable in mature virions as compared to immature virions3,4,10.  
The closely related Moloney murine leukemia and sarcoma viruses (MuLV and 
MuSV, respectively) have served as important model systems for the role of dimerization in 
retroviral infectivity. Recent work indicates that a compact region of ~170 nts in MuLV and 
MuSV, the minimal dimerization active sequence (MiDAS), is sufficient for dimerization in 
vitro14; overlaps with sequences sufficient to cause heterologous RNAs to be packaged as 
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dimers into new virions4; and  forms high affinity interactions with the viral Gag protein15. 
Structural analysis of the MiDAS RNA supports a consensus model for the dimerization 
domain that involves three major structural components (Fig. 3.1)16-18: two conserved self-
complementary sequences, PAL1 and PAL216,17,19-21 (also commonly called SL-B′ and SL-B, 
respectively) that form extended intermolecular duplexes in the dimer and a conserved 
double stem-loop domain, SL1-SL222 (also called SLC-SLD), that forms stable loop-loop 
and tertiary interactions with the homologous domain in the second RNA strand16-18,23. 
The absolute minimum information required to understand the fundamental role that 
genomic RNA dimerization plays in retroviral biology is an accurate structural model for the 
initial, monomer, state and for the immature and mature dimer structures. In addition, it is 
essential that the structures studied in detail in vitro be correlated with their correct biological 
states in virions. In this work, I sought to address two key issues regarding the structure of 
the dimerization domain in MuLV and MuSV. First, while there is an emerging consensus 
that a compact region of the MuLV and MuSV mediates dimerization both in vitro and in 
vivo, in vitro structural analyses have lead to different, often conflicting, models for the 
dimerization domain14,16,24,25. Although MuLV and MuSV have highly similar sequences in 
the dimerization domain, they do contain single-nucleotide differences, most of which reside 
in a flexible domain14 characteristic of the monomer state; it is not clear the extent to which 
these sequence differences modulate the respective RNA structures. Second, it has not been 
established whether any RNA structures analyzed in vitro correspond to those that exist in 
intact virions. Moreover, if in vitro studies do accurately recapitulate the RNA structures 
involved in dimerization and selective packaging by Gag, there is currently no information 
regarding whether these structures model the immature or mature genomic RNA dimer. 
55
Monomer
Dimer
oCB
O
A
5' 3'
205 374
MiDAS
PAL1 PAL2 SL1 SL2
46 nts 115 nts
621
AUG
60  
+1
Figure 3.1 Design and dimerization behavior of the in vitro MuLV RNA construct. A. RNA 
construct used for SHAPE analysis, containing the MiDAS and flanking viral sequences. 
Major dimerization sites are indicated: PAL1 and PAL2, palindromic sequences; SL1-SL2, 
stem loop domain. Fluorescent DNA primer for reverse transcription is represented by an 
arrow. B. Dimerization of the in vitro RNA construct, visualized by nondenaturing gel 
electrophoresis. O, gel origin.
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I use RNA SHAPE chemistry26,27 to map the MuLV MiDAS structures in both 
monomer and dimer in vitro states and then compare the structure of the dimer with authentic 
RNA dimers, gently extracted from mature virions. The structure of the MiDAS domain for 
MuLV is nearly identical to that previously mapped for MuSV RNA16,18. Sequence 
differences between these two RNAs are largely confined to a flexible domain and simply 
cause different sets of interconverting structures to be favored in this domain. Secondary 
structure models for in vitro and ex virio dimers are almost identical, indicating that in vitro 
dimerization accurately recapitulates the structure of the mature retroviral dimer. The 
corollary is that there currently exists no information regarding the structure of the immature 
dimer initially recognized and packaged by the retroviral Gag protein.  
 
3.2 Results 
 3.2.1 Mapping MuLV RNA structures by SHAPE chemistry. I first studied an 
MuLV RNA transcript that spans the previously identified minimal dimerization active 
sequence (MiDAS)14, flanked by 5' and 3' viral sequences of 46 and 115 nts, respectively 
(Fig. 3.1 A). The dimer is formed by heating the monomeric RNA at 60 °C for 30 min under 
roughly physiological ionic conditions (Fig. 3.1 B). The monomer and dimer forms of this 
RNA run as compact, well-defined, species in non-denaturing gels, indicating that both states 
fold to homogeneous structures.  
 A major goal of this work is to establish how well RNA dimers generated in vitro 
correspond to the structure of retroviral RNA genomes in real virions. I therefore also 
analyzed the structure of the MiDAS domain from authentic genomic MuLV RNA, isolated 
from virions under non-denaturing conditions that preserve the dimeric state of the RNA3,4. I 
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term this RNA the ex virio dimer. 
 I used RNA SHAPE chemistry26,27 to define the structures of the MiDAS monomer 
and both the in vitro and ex virio dimer species. SHAPE uses an electrophilic reagent, 1M7 
(1-methyl-7-nitroisatoic anhydride)28, that reacts selectively at the 2'-hydroxyl position of 
flexible nucleotides to form 2'-O-ester adducts. The reaction occurs preferentially at flexible 
RNA sites because these nucleotides are better able to adopt local conformations that 
enhance the reactivity of the 2'-hydroxyl group26. Nucleotides tagged with 2'-O-adducts are 
detected as stops to reverse transcriptase-mediated primer extension. Extension reactions are 
performed using fluorescently-labeled DNA primers and resolved by capillary 
electrophoresis28,29.  
 The output from a SHAPE experiment includes three components: a plus (+) reagent 
trace (blue), a background trace (–) that omits the reagent (green), and a deoxynucleotide 
sequencing ladder which is used to assign sites reactive towards 1M7 (red, in Fig. 3.2). Peak 
heights in the plus reagent trace are proportional to the degree of local flexibility at each 
nucleotide in the RNA. Thus, flexible nucleotides appear as tall peaks; whereas nucleotides 
that participate in strong base pairing or tertiary interactions have reactivities near the 
background. These reactivity profiles provide a wealth of information regarding the 
secondary structure of the MuLV dimerization domain in both monomer and dimer states. In 
addition, the reproducible nature of the SHAPE analysis facilitate quantitative comparisons 
between the MuLV monomer and dimer states studied in this work and with the closely 
related MuSV structures determined previously14,16.  
 I computed the absolute reactivity at each nucleotide within the MiDAS domain by 
integrating individual peak areas and subtracting the background from the (+) reagent areas. 
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Figure 3.2 Absolute SHAPE reactivities for monomer (A), in vitro dimer (B) and ex virio 
dimer (C). Blue, (+) 1M7; green, (-) 1M7; red, G sequence. 
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Absolute reactivity values for the in vitro monomer and dimer states are shown using step 
histograms (black and gray lines, respectively, Fig. 3.3 A). A reactivity difference plot (Fig. 
3.3 B) was created by subtracting nucleotide reactivities for the monomer state from those of 
the dimer. Positions that are more flexible in the monomer are represented by black columns, 
while nucleotides that become more flexible in the dimer are shown as gray columns. I 
observe extensive differences in local nucleotide flexibility between the MuLV monomer 
and dimer states (Fig. 3.3), indicative of major structural rearrangements upon dimerization. 
 
 3.2.2 Structure of the MuLV monomer. I developed secondary structure models for 
the MuLV monomer (Fig. 3.4) by using SHAPE reactivity information to impose a quasi-
energetic constraint in a thermodynamic-based RNA structure prediction algorithm30. 
Nucleotides with high SHAPE reactivities were penalized if they occurred in base-paired 
region, whereas nucleotides with near-zero reactivities were given a small thermodynamic 
bonus for being base-paired. Predicted structures were evaluated visually using secondary 
structure models annotated according to their SHAPE reactivity: red, orange and black for high, 
medium and low SHAPE reactivities, respectively.  
SHAPE analysis of the MuLV MiDAS monomer (Figs. 3.3 and 3.4 A) recapitulates 
almost exactly the secondary structure proposed for this region based on the MuSV 
sequence14. Thus, at PAL1, nucleotides 205-213 and 222-227 are mostly unreactive, while 
214-221 are highly reactive, consistent with formation of a stem-loop. Nucleotides 228 and 
229 are flexible, supporting the existence of a linker that connects the PAL1 stem-loop to the 
rest of the monomer. Nucleotides in the SL1-SL2 domain (316-370) have a low reactivity 
overall, suggesting extensive base-pairing and tertiary interactions in this region. In SL1, 
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Figure 3.4 Secondary structures for MuLV MiDAS monomer. A. Structure of the entire 
MiDAS monomer. PAL2 sequence is indicated with a line. The 231-315 domain is shown in 
brackets. B,C. Interconvertible structures for the 231-315 domain. Nucleotides are colored 
according to their SHAPE reactivity: red, >0.7; orange, 0.3-0.7; black, <0.3; gray, not 
analyzed. Nucleotide differences between MuLV and MuSV are circled.
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unreactive nucleotides are punctuated with few flexible nucleotides (319 and 337-341), 
consistent with formation of two distinct bulges. Reactive nucleotides between 350 and 354 
indicate that SL1 and SL2 are connected by a flexible linker. Between the PAL1 stem-loop 
and the SL1-SL2 domain, nucleotides 231-241 and 305-315 are constrained, while the 
majority of the positions in the large intervening loops (nts 242-304) are reactive. This 
pattern of reactivity suggests that nucleotides 242-304 form a well-defined flexible domain 
which is linked to the rest of the RNA via a stable anchoring helix (Fig. 3.4 A). An identical 
overall architecture was identified previously for MuSV14. Within the flexible domain, there 
are four nucleotide differences between MuLV and MuSV. 
The net effect of sequence differences between MuSV and MuLV is to cause slightly 
different monomer structures to be favored in the flexible domain (nts 242-304). For 
example, in the most stable MuLV predicted structure, PAL2 forms a stem-loop (supported 
by low reactivity at nts 279-287 and 295-299 and high reactivity for nts 288-294, Figs. 3.3 A 
and 3.4 A). However, the lowest energy predicted structure contains numerous local 
inconsistencies. For example, nucleotides 243-245 are reactive but, nevertheless, are 
predicted to be base paired in this contributing structure (Fig. 3.4 A). I infer that the flexible 
domain does not form a single structure but, instead, exists in an equilibrium between 
different secondary structures (Fig. 3.4 B,C). Roughly three interconverting structures 
appear to be sufficient to account for the global pattern of SHAPE reactivity. These three 
structures have free energies of formation that differ by only 3 kcal/mol, or roughly the 
energy of a single G-C base pair31.  
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3.2.3 Conformational changes that accompany formation of the in vitro dimer. 
Comparison of the overall reactivity profiles for the MuLV monomer and dimer states 
indicates that numerous conformational changes accompany in vitro dimerization reaction 
(Fig. 3.3 A). These changes are readily visualized in a difference analysis (Fig. 3.3 B) and 
show that nucleotides in both PAL1 and PAL2 undergo significant conformational changes 
and become unreactive in this structural transition. Loss of reactivity in PAL1 and PAL2 is 
consistent with formation of extended intermolecular duplexes in the dimer (Fig. 3.6 A). 
Similar to a model previously proposed for MuSV16, SHAPE reactivities also indicate the 
anchoring duplex melts (nts 231-235 and 305-309 become flexible) and that the SL1-SL2 
domain undergoes a local conformational change (increase in reactivity at nts 314-315 and 
319 and decrease in reactivity at nts 350-352 and 348-352), consistent with elongation of 
SL1 by four base pairs during dimerization18. 
 All major interactions involving PAL1 and PAL2 duplexes and the SL1-SL2 domain 
appear configured identically in MuLV and MuSV in vitro dimers (compare Fig. 3.6 A with 
16). In contrast, the flexible domain that links PAL1 and PAL2 in the dimer state folds 
differently in MuLV and MuSV. In MuSV, this region appears to be able to form either of 
two structures: a double stem loop motif or a pseudoknot16. In the MuLV dimer state, 
SHAPE analysis is generally consistent with formation of a single predominant structure 
(Fig. 3.6 A). Nucleotides 237-240 and 276-280 are unreactive, consistent with formation of a 
five-base pair helix. This short helix terminates in a large, flexible, loop (nts 242-274), 
flanked by additional flexible nucleotides (220-235 and 281-282).  
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 3.2.4 In vitro RNA dimer folds similarly to an authentic dimer isolated from 
virions. To assess how closely the in vitro dimer resembles the dimer structure as it exists in 
infective virions, I compared SHAPE reactivity profiles for our short transcript with that for 
genomic RNA that was gently extracted from virions (compare gray and blue histograms, 
Fig. 3.5 A). I analyzed differences between these two RNAs in a quantitative way, by 
subtracting individual nucleotide reactivities of the in vitro from the ex virio dimer (Fig. 3.5 
B). Positions that are more reactive in the ex virio versus in the in vitro dimer are shown as 
blue and gray columns, respectively.   
 Strikingly, SHAPE profiles of the in vitro and ex virio dimers are superimposable in 
all regions spanning the key elements – PAL1, PAL2 and the SL1-SL2 domain – that 
function to stabilize the dimer state17 (compare gray and blue columns, Fig. 3.5 B): PAL1 
(nts 210-219), PAL2 (nts 283-298) and SL1-SL2 domain (nts 310-371). I infer that these 
elements form precisely the same interactions in both in vitro-generated and authentic ex 
virio dimers. These results imply that the structure of the in vitro dimer closely resembles the 
ex virio dimer.  
 In contrast to this overall pattern of near-identical reactivities, marked differences are 
observed for the in vitro and ex virio dimers in the flexible domain (compare gray and blue 
traces between nts 224-261, Fig. 3.5 A). Within the flexible domain, there are two distinct 
structural differences. A continuous 10-nt RNA region in the flexible domain (nts 243-252) is 
essentially completely unreactive in the ex virio dimer, whereas, nucleotides in the in vitro 
dimer are reactive. These data suggest that these nucleotides form strong base pairs, but only 
in the authentic genomic RNA extracted from virions (ex virio dimer, Fig. 3.6 B). 
Nucleotides 5' of this ex virio-specific base-pairing interaction (at nts 220-236) are more 
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Figure 3.6 Secondary structure model for MuSV MiDAS dimer. A. Structure of the entire in 
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reactive in the ex virio than in the in vitro dimer (blue columns, Fig. 3.5 B). I infer that the 
long-range interaction also induces a local structural rearrangement that renders these 
nucleotides more flexible. The SHAPE reactivity pattern for the ex virio dimer is robust and 
persists even if the ex virio dimer is denatured and allowed to re-dimerize in vitro (data not 
shown). These experiments strongly support the interpretation that the structural differences 
between the in vitro versus ex virio dimers reflect a long-range interaction that can only form 
in the longer ex virio RNA. I searched for potential candidate regions that are predicted30 to 
pair stably with nucleotides 243-252 in the ex virio RNA. I identified a 7-nt sequence (663-
669), that lies ~300 nts 3' of the MuLV MiDAS domain, that is capable of forming a perfect 
helix with MiDAS nucleotides 244-250 (Fig. 3.6 B).  
  
3.3 Discussion 
3.3.1 Comparison of MuLV and MuSV MiDAS monomer and dimer states. In an 
effort to characterize a consensus structure for the RNA dimerization domain of gamma 
retroviruses, our laboratory has analyzed two closely related model systems, MuLV and 
MuSV. In this work, I analyzed the structures of the monomer and dimer states for MuLV 
RNA using SHAPE chemistry and compared these structures with those previously 
determined for MuSV RNA14,16. I observed that the major monomer and dimer structures 
fold identically in the two viruses. In the monomer, PAL1 and the SL1-SL2 domain form 
stable stem loops and PAL2 is part of a large flexible domain supported by an anchoring 
helix (Fig. 3.4 A). In both murine viruses, these elements undergo similar conformational 
changes upon dimerization (Fig. 3.6 A and 16): PAL1 and PAL2 form intermolecular 10 and 
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16-bp heteroduplexes, respectively; the anchoring duplex breaks; and SL1 elongates by 4-bp 
in the dimer.  
Despite similar overall secondary structures, sequence differences of only five 
nucleotides in the MiDAS domains of MuLV and MuSV leads to measurable structural 
differences in both viral monomer and dimer states. Four of these five nucleotide differences 
occur in the flexible domain and we find that, while both viruses contain flexible domains, 
this domain prefers different structures in each virus. In the monomer form for each viral 
RNA, the flexible domain is best characterized as interconverting between several, nearly 
isoenergetic, structures (compare Fig. 3.4 and 14). In the most stable MuSV monomer 
structure, PAL2 is unstructured14, while it forms a distinct stem loop in MuLV (Fig. 3.4 A). 
In MuLV, the PAL2 region appears reactive in the SHAPE monomer trace (Fig. 3.2 A), 
suggesting that the flexible domain only transits through, but does not become trapped in, a 
secondary structure that constrains PAL2. It is conceivable that an unstructured PAL2 region 
lowers the energy cost for melting base pairs in the monomer to dimer transition. Despite 
sequence differences, this structural feature appears to be conserved in MuSV14 and possibly 
in other gamma retroviruses.   
SHAPE analysis was able to accurately recapitulate the structures for PAL1 and 
PAL2 extended duplexes as well as for the SL1-SL2 domain in both viruses. However, a 
small, 4-nt, difference between MuLV and MuSV in the dimer flexible domain generates 
different foldings for this region. In MuSV dimer, this domain forms two stem loops or a 
pseudoknot16, while in MuLV it remains mostly unstructured (Fig. 3.6 A,B). To date, 
phylogenetic covariation analysis is the most powerful method to determine consensus 
structures for large RNAs32-34. However, this method is not applicable to regions with almost 
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identical sequences as is the dimerization domain of gamma retroviruses22. I show that 
SHAPE analysis not only reports conserved structures in regions with highly conserved 
sequences (PAL1, SL1-SL2), but can also detect structural diversity for regions with 
conserved sequences (flexible domain). 
 
3.3.2 In vitro RNA dimerization reveals the structure of the mature dimer. After 
being exported from the infected cell, new viral particles undergo a complex maturation 
process that renders the viruses infectious12. Macroscopic viral maturation also involves a 
parallel, microscopic, maturation of the genomic RNA dimer. The structures of the immature 
and mature dimers appear to be different as the immature dimer is less stable and less 
compact than the mature dimer3. In vitro studies have proven a powerful way to analyze the 
length of the minimal dimerization domain; however, the dimers formed in vitro in the 
context of short RNAs, using “near”-physiological ionic and temperature conditions might 
differ structurally from their in virio homologues. Additionally, for efficient in vitro 
dimerization, longer retroviral RNA fragments require either the presence of the 
nucleocapsid protein or unphysiological temperatures (60 ºC). Therefore, a correlation 
between the in vitro and in virio dimer structures is fundamental for studying the retroviral 
RNA dimer. Moreover, if the in vitro dimer structure is indeed biologically relevant, a 
correlation with the mature or the immature RNA dimer forms remains to be assessed.  
I have addressed this issue directly, by comparing the structures of a dimer obtained 
in vitro and an ex virio dimer that has been extracted from mature MuLV virions. The 
structure of this in vitro dimer proves to be strikingly similar to the mature ex virio dimer 
structure for the major dimerization elements: PAL1 and PAL2 extended duplexes and the 
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SL1-SL2 domain. This analysis demonstrates that the in vitro dimer accurately corresponds 
to the mature dimer form found in infectious virions. To date, the immature dimer could not 
be structurally characterized by in vitro structural analysis methods, suggesting that this 
species might be a kinetic trap or a metastable intermediate state on the genomic dimer 
production pathway.  
 
 3.3.3 A long-range interaction involving MiDAS. Although the overall reactivity 
pattern is identical for the in vitro and the ex virio dimers, SHAPE analysis reveals 
differences in the least structured region (flexible domain, nts 220-282). Due to high 
resolution information generated by SHAPE, I observe a significant and reproducible loss of 
reactivity for a series of 10 nucleotides in the flexible domain of the ex virio dimer (compare 
nts 243-252 in Fig. 3.6 A and B). Simultaneously, 5' neighboring nucleotides 220-235 
undergo a compensatory rearrangement to a more flexible conformation. Two pieces of 
information suggest that nts 243-252 are part of a long range interaction with a sequence 
outside our in vitro construct. First, these 10 nucleotides appear to be unreactive towards 
SHAPE reagent only in the context of long RNAs, not in the short, in vitro, construct. 
Second, the same ex virio low SHAPE reactivity pattern can be recreated in vitro, by 
denaturing the ex virio RNA and then allowing it to re-dimerize.  
Formation of long-range interactions presumably helps compaction of the retroviral 
dimer and, thus, can be a part of the viral maturation process. Long-distance interactions 
have been previously proposed in different retroviral systems35-37 and have been implicated 
in important viral processes such as regulation of Gag transcription, by obstructing the AUG 
codon38 and in splicing, by blocking the binding of polyadenylation factors to the poly(A) 
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site39. Using classic in vitro mapping methods, however, it is often difficult to detect these 
interactions in an RNA. I demonstrate here that RNA SHAPE analysis easily detects long-
range interactions even if the pairing partners are hundreds of nucleotides away, permitting 
correct inferences about the roles of retroviral genomes. 
This work emphasizes that the structure of the mature retroviral dimer is now well 
defined. The next frontier is to find out structural differences between the mature and the 
immature genomic RNA dimers, as part of understanding the differences between infective 
and noninfective virions.  
 
3.4 Experimental procedures 
 3.4.1 Retroviral RNA transcripts. The in vitro MuLV RNA construct contained 331 
nucleotides and spanned the MiDAS domain plus flanking 5' and 3' viral sequences of 46 and 
115 nucleotides, respectively (Fig 3.1 A). These 5' and 3' flanking sequences allow SHAPE 
analysis of the entire internal MiDAS region. The DNA template for in vitro transcription 
was generated by PCR from the pRR88 plasmid40. Transcription reactions (500 µL, 37 ºC, 6 
h) contained 80 mM HEPES (pH 7.5), 40 mM DTT, 0.01% (v/v) Triton X-100, 2 mM 
spermidine, 10 mM MgCl2, 2 mM each nucleoside triphosphate, ~25 µg of DNA template, 
250 U of SUPERase-In (Ambion), and 0.07 mg/mL polymerase. The RNA was purified by 
denaturing gel electrophoresis [6% (w/v) polyacrylamide, 7 M urea], excised from the gel, 
eluted overnight into ½× TBE [45 mM Tris-borate (pH 8), 1 mM EDTA] at 4 ºC, 
concentrated by ethanol precipitation, and stored in 1× TE [10 mM Tris (pH 8), 1 mM 
EDTA] at -20 ºC. 
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3.4.2 Native gel analysis. Internally [32P]-labeled RNA was combined with identical 
unlabeled 331-nt RNA (final concentration 111 nM) in 6.4 µL. The RNA was denatured at 
90 °C for 3 min, snap-cooled on ice for 2 min, treated with 5× dimer buffer (3.2 µL; 250 mM 
HEPES (pH 7.5), 1 M potassium acetate (pH 7.5), 25 mM MgCl2) and loading dye (6.4 µL; 
30% glycerol, 0.01% xylene cyanol and bromophenol blue) and either kept in ice (monomer) 
or incubated at 60 °C for 30 min (dimer). Monomer and dimer bands were resolved on a non-
denaturing gel (6% polyacrylamide, 1× TBE), run at a gel temperature of 25 °C (1.5 h at 7 
W). 
 
 3.4.3 Viral preparation. Viral preparation, RNA extraction, purification and 
quantification were performed by Julian W.J. Bess (HIV Drug Resistance Program, National 
Cancer Institute, Frederick, Maryland). Virus was obtained from NIH-3T3 cells (10 L) 
infected with MuLV (isolate SL658 DN). Virus was recovered from culture supernatants by 
single or double banding in sucrose gradients as described41. Virus pellets were resuspended 
in TNE (0.01 M Tris-HCl (pH 7.2), 0.1 M NaCl, and 1mM EDTA) at final concentrations of 
1000× or 5000×, relative to the starting culture volume and aliquots were stored at -70 °C. 
 
 3.4.4 Ex virio RNA dimer extraction and quantification. For preparation of whole 
MuLV genomic RNA, (~2 × 1013 virions) were pelleted by ultracentrifugation (Beckman 
SW-41 rotor; 37,000 rpm, 4 °C, 1 h).  Pellets were resuspended in 1 mL of lysing buffer [50 
mM TRIS (pH 7.4), 10 mM EDTA, 1% (w/v) SDS, 100 mM NaCl, 100 µg/mL proteinase K, 
120 µg/mL glycogen], incubated at 25 °C for 45 min, and extracted three times with an equal 
volume of phenol:chloroform:isoamyl alcohol and once with an equal volume of chloroform.  
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Samples were precipitated in 70% ethanol with 0.3 M sodium acetate and stored at -20 °C. 
RNA amounts were quantified by real-time reverse transcriptase PCR as described42, and 
amplifying gag nucleotides 681-757 (Genbank: J02255; forward primer, 5'- CGG ATC GCT 
CAC AAC CAG T-3'; reverse primer, 5'-AAG GTT GGC CAT TCT GCA GA-3'; and 
fluorescent probe, 5'-FAM-TAG ATG TCA AGA AGA GAC GTT GGG TTA CCT-
TAMRA-3').  
 
 3.4.5 SHAPE analysis of MiDAS monomer and dimer states. In vitro-generated 
RNAs (2 µL; 2 pmol) were heated at 95 ºC for 3 min in water (10 µL), snap-cooled on ice for 
2 min and treated with 3× dimerization buffer [6 µL; 150 mM HEPES (pH 7.5), 600 mM 
potassium acetate (pH 7.5), 15 mM MgCl2]. Monomers were allowed to equilibrate for 2 min 
at 37 ºC prior to modification; dimers were created by heating (30 min, 60 ºC). Ex virio RNA 
was not subjected to any heating and denaturing step, but was simply allowed to pre-
equilibrate in dimerization buffer for 15 min. 2'-Hydroxyl modification was performed by 
treating a monomer or dimer RNA (9 µL) with 1-methyl-7-nitroisatoic anhydride (1M7) (1 
µL; 20 mM) in anhydrous dimethyl sulfoxide (DMSO)28 for 2 min (~ 12 half lives) at 37 ºC. 
Control reactions were obtained by addition of DMSO, omitting 1M7. The reactions were 
recovered by ethanol precipitated and resuspended in 6 µL ½× TE.  
 
 3.4.6 Primer extension. Three DNA primers of identical sequence (5'- GGU GCA 
CCA AAG AGU CCA AAA GC-3'), but labeled with different fluorophores (Cy5, Cy5.5 or 
IR800) were used to analyze the entire MiDAS RNA construct. Primers were designed to 
anneal to a native viral sequence 47 nucleotides 3' of the MiDAS domain (nts 422-445). 
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Fluorescent DNA primers (0.5 µL; 2 pmol) were annealed to the modified RNA (6 µL; 1 
pmol) by heating at 65 °C and 45 °C, each for 5 min. Reverse transcription buffer [3 µL; 167 
mM Tris (pH 8.3), 250 mM KCl, 10 mM MgCl2, 1.67 mM each dNTP, 16.7 mM DTT] was 
added and primer extension was performed with Superscript III reverse transcriptase 
(Invitrogen) (0.5 µL; 100 U) at 45 °C (1 min), followed by incubation at 52 °C and 65 °C, 
each for 5 min. Reactions were quenched by cooling at 4 °C and adding 3 M sodium acetate 
pH 5.2 (1 µL). A dideoxy guanosine sequencing marker was obtained by adding 0.25 µL 
ddCTP (10 mM) to the primer extension reaction, using unmodified RNA. The three 
reactions (plus and minus 1M7 and dideoxy sequencing) were combined, ethanol 
precipitated, and resuspended in deionized formamide (40 µL). cDNA fragments were 
resolved by capillary electrophoresis using a CEQ 2000XL DNA Fragment Analysis 
sequencer (Beckman Coulter).  
 
 3.4.7 Data processing and structure prediction. Raw sequencer traces were 
corrected for dye variation and signal decay, and peak intensities were integrated using a 
custom software package29. Reactivity sets were normalized by dividing the absolute peak 
intensities by the average of the 8% (14 nts) most reactive peaks after exclusion of the first 
2% (3 nts). RNAstructure43 was used to generate secondary structure models by utilizing 
SHAPE-generated reactivities as quasi-energetic constraints.  
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Chapter 4 
 
 
 
 
Direct Analysis of Gag and Nucleocapsid Binding Sites in the 
Dimerization Domain of Mature Moloney Murine Leukemia 
Viral RNA Genome 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1 Introduction 
 With every round of infection, retroviruses undergo a self-assembly process to yield 
new infectious viral progeny. During assembly of nascent viral particles, retroviruses 
specifically package the genomic RNA, in a dimeric structure, against an immense excess of 
non-viral cellular RNA1-4. The packaging function is carried out by Gag, a viral polyprotein 
that specifically recognizes the genomic RNA dimer1,5,6.  
The closely related Moloney murine leukemia and sarcoma viruses (MuLV/MuSV) 
are important model systems for understanding the mechanism of retroviral RNA 
dimerization and packaging1,6-8. As judged by multiple independent approaches, a consensus 
has emerged that there exists a minimal dimerization active sequence (MiDAS) that is the 
sine qua non for efficient dimerization in vitro9 and for dimerization3 and Gag binding10 in 
vivo. Both the monomer and dimer structures for the MuLV/MuSV dimerization domains are 
now well understood (Fig. 1) (Chapter 3 and 9,11). Moreover, dimers spanning the MiDAS 
sequences generated artificially in vitro accurately report the structure of mature genomic 
RNA dimers gently extracted from authentic virions (Chapter 3).  
Whereas the sequences required for dimerization and for efficient Gag binding appear 
to be well defined3,9,10, the mechanism by which Gag specifically recognizes the genomic 
RNA dimer is not known. As it is the dimer that is packaged selectively in all normal 
retroviruses, the RNA packaging signal likely represents a combination of primary sequence 
information that must be then presented in a special and active three-dimensional structural 
context. An emerging theme is that the nucleocapsid (NC) protein, a constituent of the viral 
Gag polyprotein, specifically recognizes guanosine residues in single stranded regions12-16. 
Specific guanosine binding is mediated by conserved zinc finger motifs found in most 
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Figure 4.1 Secondary structure models for MuLV MiDAS RNA in the monomer and dimer 
sates. Protein-binding sites at UCUG tandem sequences are boxed. Major interaction sites 
(PAL1, PAL2 and the SL1-SL2) and a previously proposed (Chapter 3) intramolecular long-
range interaction are labeled. 
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retroviral Gag proteins5,12. However, the presence of numerous single stranded guanosines in 
retroviral genomes and in cellular RNAs, in general, suggests that there must be additional 
determinants that govern Gag-RNA recognition. An attractive hypothesis is that Gag does 
not merely recognize guanosine residues but, instead, guanosines presented in a special 
structural context that guides assembly. 
 Specific Gag or NC RNA binding sites, presented in their biologically active context, 
have been nearly impossible to identify to date because relatively large RNA regions are 
required for packaging. Moreover, it is generally difficult to differentiate between the 
consequences of formation of direct interactions between proteins and the genomic RNA 
versus the secondary RNA conformational changes that accompany protein binding. Finally, 
it is not yet clear to what extent in vitro analyses using purified components reproduce 
protein binding inside authentic virions.  
In this work, I use SHAPE chemistry17,18 to analyze the dimerization domain directly 
inside infectious MuLV particles and I further identify the specific contacts between the 
MiDAS RNA and the retroviral Gag and NC proteins by selectively disrupting these 
interactions in situ. I then confirm specific Gag and NC binding sites within the MiDAS by 
in vitro reconstitution experiments. RNA recognition by both Gag and NC is mediated by a 
minimal packaging signal formed by tandem UCUG sequences flanked by stable base-paired 
regions, a motif only found in the dimeric RNA state. 
 
4.2 Results 
4.2.1 Strategy. I previously mapped the MuLV MiDAS monomer (Fig. 1 A) and 
dimer states (Fig. 1 B) in vitro and for an authentic genomic RNA gently extracted from 
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virions (Chapter 3). Upon dimerization, the self-complementary PAL1 and PAL2 sequences 
form extended intermolecular duplexes and the SL1-SL2 double stem loop motif forms loop-
loop interactions through their apical tetraloops11,19,20. In the dimeric RNAs isolated from 
virions, there exists a large flexible domain between the PAL1 and PAL2 duplexes and 
sequences within this domain form a long-distance intramolecular interaction with a 
sequence outside the MiDAS domain (Fig. 1 B). The dimer formed by the MiDAS sequence 
in vitro corresponds exactly to the structure of the mature RNA dimer extracted from virions 
with the exception that the in vitro dimer is too short to form the long-range interaction 
(Chapter 3). In this work, I map the structure of the genomic RNA dimer directly inside 
authentic virions (see in virio state, Fig. 2 A) and detect, in principle, all possible 
contributions of the viral environment to the structure of the dimer. 
Inside the virion, either the nucleocapsid (NC) protein or the NC domain of the intact 
Gag is the main protein ligand for the RNA dimer. Thus, mapping the structure of the RNA 
dimer in virio provides information about all NC binding sites and for all possible RNA 
conformational changes induced by protein binding. To analyze the effects of NC protein 
binding to RNA inside virions, I exploit the fact that each NC protein interacts with RNA, in 
part, via a conserved zinc finger motif (Fig. 2 B)5,7,12-15. An intact zinc finger structure is 
required for formation of specific and high-affinity specific NC-RNA interactions and for 
efficient RNA packaging21,22.  
The use of zinc-ejecting agents has proven to be an elegant approach to disrupt the 
structure of the NC zinc finger motifs, and thereby, NC-RNA interactions, both in vitro23 and 
inside virions16,24. These reagents are especially powerful since they only target the NC 
domain and leave the overall virus architecture intact25,26. In our study, I use the mild 
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Figure 4.2 Evaluation of NC binding to the genomic RNA dimer. A. Schematic for SHAPE 
analysis of authentic genomic RNA dimers. NC is shown in orange. AT-2 is the zinc ejecting 
agent, aldrithiol. B. NMR structure of MuLV NC zinc finger bound to a UCUG Sequence12. 
NC zinc finger is shown in orange with the Zn2+-coordinating atoms in red and the tyrosine 
and tryptophan residues in yellow. The UCUG RNA sequence is shown in dark blue with the 
first U and the final G in green. 
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oxidizing compound, 2,2'-dithiodipyridine (Aldrithiol-2, AT-2)24 that compromises zinc 
finger structure by disrupting native cysteine-Zn2+ interactions and by inducing non-native 
cysteine disulfide formation (AT-2 treated, Fig. 2 A).  
I use RNA SHAPE chemistry17,18 to analyze the structure of the dimerization domain 
in MuLV genomic RNAs. SHAPE chemistry exploits the fact that the 2'-hydroxyl group in 
flexible nucleotides react preferentially with electrophilic reagents to form 2'-O-ester 
adducts. Nucleotides tagged with 2'-O-adducts are then detected as reverse transcriptase 
stops in a subsequent primer extension reaction. I performed the extension reactions using 
fluorescently-labeled DNA primers, resolved by capillary electrophoresis16,27.  
 I use two different SHAPE reagents in this work. To map RNA structure inside 
virions, I use NMIA (N-methyl-isatoic anhydride), previously shown to permeate the virion 
membrane16. NMIA reacts relatively slowly with RNA (reaction is complete after 30 min), 
which allows the reagent to diffuse within the virion and modify the genomic RNA. For in 
vitro analyses, I used 1M7 (1-methyl-7-nitroisatoic anhydride)27, a more reactive electrophile 
(reaction complete in 70 s). Control experiments showed that 1M7 and NMIA give virtually 
identical results in vitro (data not shown). None of the conclusions of this work are affected 
by the use of the two reagents. 
 
4.2.2 Structural analysis of authentic MuLV genomic RNA dimers. A SHAPE 
experiment involves three sets of information (Fig. 3): plus (+) and minus (-) reagent traces 
(blue and green, respectively), and a deoxynucleotide sequencing trace used to assign peak 
positions (red). Flexible nucleotides are reported as tall peaks in the (+) reagent trace; 
whereas, nucleotides that participate in stable base pairing or tertiary interactions have 
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Figure 4.3 Representative SHAPE analysis of ex virio, in virio and AT-2 treated dimers. (+) 
and (-) reagent traces are shown in blue and green, respectively; guanosine sequence is red; 
regions that show largest SHAPE reactivity differences are underlined.  
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reactivities near the background. The (-) reagent control reports RNA degradation and 
intrinsic pauses by reverse transcriptase (notice a small number of peaks in the green traces, 
Fig. 3). 
 I compared SHAPE reactivity traces for the genomic RNA dimer that had been gently 
extracted from mature virions (ex virio, Fig. 3 A) with both in virio (Fig. 3 B) and AT-2 
treated (Fig. 3 C) dimers. As expected, the stable structures that form and are characteristic 
of the dimer state show low SHAPE reactivities. The PAL1 and PAL2 intermolecular 
duplexes and the SL1-SL2 domain are unreactive in each of the ex virio, in virio and AT-2 
treated states, indicating that these structures form in all three dimers. In strong contrast, I 
observe distinct changes in nucleotide reactivity in the flexible regions that link these 
structural elements. For example, comparison of the ex virio with the in virio RNA indicates 
that some regions are less flexible (nts 220-235 and 299-309) and others are more flexible 
(nts 246-261, 272-279 and 338-341) inside the authentic virion as compared with the 
extracted ex virio RNA.  
Differences between the ex virio and in virio states will reflect both protein binding 
and different local RNA foldings as stabilized by the virion environment. NC-RNA 
interactions inside the virion were compromised by treatment with the AT-2 zinc ejecting 
agent (the AT-2 treated state). The SHAPE reactivity profiles for the in virio and AT-2 
treated states show significant differences especially in their flexible regions (nts 220-282, 
299-309 and 338-341; compare Figs. 3 B and 3 C). In contrast, the SHAPE reactivity profiles 
for ex virio and AT-2 treated dimers are highly similar. These data suggest that, first, my ex 
virio dimer robustly reflects the structure of the dimeric RNA inside virions and can be used 
as a reference state; second, AT-2 treatment efficiently disrupts most NC-RNA interactions, 
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as the AT-2 treated dimer largely resembles the ex virio and not the in virio state. 
 
4.2.3 Quantitative analysis of MuLV genomic RNA structure. The absolute 
SHAPE reactivity at each nucleotide in the ex virio, in virio and AT-2 treated dimer states 
was obtained by integrating the peaks in the (+) reagent traces and subtracting background 
(step histograms, Fig. 4 A). Because SHAPE reactivities are highly reproducible and 
quantitative28, differences between two reactivity profiles can be robustly identified in a 
reactivity difference plot (Fig. 4 B). RNA positions that are less reactive inside the virion (in 
virio) are reported as positive amplitudes, while nucleotides that are more flexible in the 
virion have negative amplitudes. The three dimers have similar reactivities for the major 
RNA structures that mediate dimer formation: the PAL1 and PAL2 duplexes and the SL1-
SL2 domain. All three states clearly have similar RNA secondary structures. 
Three regions are less reactive in virio, and therefore in the presence of viral proteins 
than in the ex virio dimer (positive amplitudes, Fig. 4 B): these include nucleotides 
immediately 3' of PAL1 (220-235) and 3' of PAL2 (299-309) and in the GGAA bulge in SL1 
(338-341). Conversely, a large group of nucleotides in the flexible domain are more flexible 
inside virions as compared to the other two states (negative columns, Fig. 4 B), indicating 
that the virion environment relaxes the local structure in this region. These positions include 
most of the nucleotides in the 243-252 region, that were previously proposed to participate in 
a long-range interaction (Fig. 1 B) (Chapter 3), suggesting that NC weakens the long-range 
interaction. Nucleotides 276-279 also increase in reactivity in virio, while nucleotides 237-
241 are less reactive. I infer that NC partially melts the 5-bp duplex in the flexible domain 
after binding to the 5' side of this short helix (see Fig. 1).  
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Figure 4.4 Structural differences in the MiDAS domain of genomic dimers. A. 
Superimposed SHAPE reactivity histograms for the ex virio (light blue), in virio (red) and 
AT-2 treated (dark blue) dimers. Broken lines indicate few nucleotides not analyzed because 
of high background. B. Difference plot calculated by subtracting the in virio intensities from 
those of the ex virio (light blue columns) or AT-2 treated (dark blue columns) dimers. 
Positive and negative amplitudes indicate nucleotides that show increased or reduced 
flexibility, respectively, in virio as compared to the other two states. Strongest sites of 
increased reactivity in the ex virio and AT-2 treated states are underlined.
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4.2.4 Confirming high affinity nucleocapsid binding sites in vitro. The in virio 
analysis has the significant advantage of reporting the structure of a near-native RNA with all 
native protein contacts intact. Analysis of the difference between this state and the ex virio 
and the AT-2 treated states can, in principle, be very complex and it is possible that 
manipulating the RNAs in the latter two states might alter the RNA structure. I, therefore, 
characterized the structure of MiDAS dimer by adding either Gag or NC back to an RNA 
dimer formed in vitro. I analyzed a 331-nt long dimeric RNA transcript (Chapter 3) that 
spans the MiDAS domain and is embedded within short flanking viral sequences. This 
construct forms homogenous monomer and dimer populations and accurately recapitulates 
the structure of the ex virio dimer, with the exception that the long-range interaction 
involving nucleotides 243-252  (Fig. 1 B)  the downstream nucleotides are absent.  
I initially evaluated RNA binding by Gag and NC to the MiDAS RNA dimer under 
near-physiological ion conditions (200 mM potassium acetate, 5 mM MgCl2), but observed 
no NC-specific effects and relatively weak effects of Gag binding. I observed clear structural 
changes, however, upon addition of Gag and NC at lower ionic strength (40 mM NaCl or 
potassium acetate, 0.8 mM MgCl2). I, therefore, first formed the dimer in a near-
physiological buffer and then diluted the samples to lower ionic strength prior to protein 
addition. Control experiments demonstrated that the dimer structure is retained when the pre-
formed dimer is diluted to the low ionic strength condition. Gag-RNA interactions were 
readily detected at a modest molar excess of Gag over RNA (5:1), whereas, detection of any 
effect of NC required a large molar excess (250:1).  
Absolute SHAPE reactivities for the Gag and NC-bound RNA dimers are shown as 
step histograms (green and orange lines, respectively; Figs. 5A and B) and compared to 
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Figure 4.5 Effect of Gag and Nucleocapsid binding the structure of the MiDAS RNA dimer 
formed in vitro. A,B. SHAPE reactivity histograms for RNA analyzed in the presence of 
either Gag or NC proteins (in color) versus in buffer alone (gray). C,D. Difference plots 
created by subtracting the (+) protein  intensities from those of the (-) protein (green and 
orange columns for Gag and NC, respectively) or subtracting the in virio intensities from 
those of the ex virio dimer (light blue columns). Positive and negative amplitudes represent 
nucleotides that are more flexible in the (-) protein vs. the (+) protein RNA, respectively. The 
single region containing reactivity differences between NC and Gag is underlined in panel D.
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MiDAS reactivities in the absence of proteins (gray). Positive and negative amplitudes (green 
and orange columns, Fig. 5 C,D) indicate nucleotides that become less or more reactive, 
respectively, upon addition of proteins. For comparison, flexibility differences between the 
ex virio and in virio dimer states are shown with blue columns (Figs. 5 C,D). Notably, 
differences observed in the SHAPE reactivity profiles for the in vitro-generated MiDAS 
RNA upon adding Gag or NC are nearly identical to the difference observed by disrupting 
NC-RNA interactions inside virions using AT-2 (compare corresponding columns in Figs. 5 
C and D). These data suggest, first, that the structures of the protein-bound dimers in vitro 
and in virio are similar and, second, that AT-2 treatment yields nearly complete disruption of 
NC-RNA interactions in virio.  
I did observe a few differences in nucleotide flexibility patterns measured between in 
vitro versus in virio. Positions 243-252 are more flexible in virio due to the missing long-
range interaction in the in vitro dimer. Nucleotides 3' of the long-range interaction (253-266) 
are stabilized by addition of Gag and NC in vitro; whereas, they become more flexible in 
virio. Finally, a single, short, region in the flexible domain (nts 220-226) becomes more 
protected by NC than by Gag, suggesting that NC probably binds tighter than Gag to these 
nucleotides.  
 
4.2.5 A consensus binding site for Gag and NC in the MuLV dimerization 
domain. SHAPE reactivity plots give quantitative information for all possible effects of the 
virion environment (Fig. 4 B), and of Gag and NC binding (Fig. 5 C,D) on the structure of 
the retroviral RNA. In many cases, these effects are reproducible, but subtle, such that 
nucleotides reactive by SHAPE chemistry become slightly more or less reactive in the 
 93
presence of viral proteins. I identified individual nucleotides that undergo the largest changes 
in reactivity after either compromising protein binding with AT-2 or in the absence of 
protein, by calculating a protection factor (Fig. 6). Nucleotides whose reactivity decreases 
significantly in the presence of Gag and NC proteins have protection factors of 2-5, whereas 
positions not affected by protein binding have a protection factor of ~0. Nucleotides that had 
near-background SHAPE reactivities (<0.15) both before and after protein removal were 
considered unaffected by protein binding. I calculated protein protection factors for four 
instructive comparisons: in virio versus (protein-free) ex virio, AT-2 treated virions versus 
the in vitro state and for the two in vitro experiments in the presence of NC and Gag (Fig. 6).  
Strikingly, the protection patterns in the intact virion (Figs. 6 A,B) or upon adding 
Gag (Fig. 6 C) or NC (Fig. 6 D) to the dimer are highly similar. For all four comparisons, 
there are strong sites of protection immediately 3' of PAL1 (nts 220-230) and PAL2 (nts 299-
309). Each of these sites contains two copies of the UCUG motif (PAL1 and PAL2 tandem 
sequences, red, Fig. 6), previously proposed to interact with NC29. The SHAPE analysis 
shows that nucleotides within the dual UCUG motifs exhibit a conserved reactivity pattern, 
such that the first U and the final G experience the strongest extent of protection (emphasized 
with red lines, Fig. 6). 
Although the overall pattern of protection is highly similar, there are important 
differences at some sites. First, in addition to the conserved protections at the tandem UCUG 
sequences, positions 220-223 also show protection, but predominantly in the ex virio versus 
in virio and the NC experiments (Figs. 6 A and D). This site apparently represents binding by 
NC via a mechanism that does not involve the zinc finger motif because it is not affected by 
AT-2 treatment (compare panels 6 A and B). Second, Gag binding in vitro induces protection 
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in the SL1 structure (Fig. 6 C) that is not seen in the other comparisons. This binding likely 
reflects either a semi-specific interaction with our recombinant Gag protein, or a protein-
induced conformational change.  
Finally, at the PAL2 tandem binding site (nts 299-309), the protection pattern induced 
by NC alone (Fig. 6 D) clearly has a different local pattern than observed for any of the other 
three comparisons. At this site, the first U in the UCUG sequences shows little or no 
protection with NC, whereas, this nucleotide is strongly protected as judged in the other three 
comparisons. I speculate that intact Gag and not the cleaved NC protein binds at this site (and 
perhaps elsewhere) in the authentic virions.  
 
4.2.6 Defining a minimal packaging motif. Direct mapping of retroviral protein-
genomic RNA interactions both inside authentic virions and in in vitro reconstitution 
experiments suggests that the minimal packaging domain spans a single sequence with the 
following consensus: UCUGURUCUG. This sequence occurs twice in the MiDAS RNA and 
is presented in a similar structural context in both cases. The single stranded tandem UCUG 
motif is flanked by base paired regions: the first motif is flanked on the 5' side by PAL1 
heteroduplex and on the 3' side by both the 5-bp helix and the long range interaction base 
pairing; the second motif is flanked on the 5' side by PAL2 heteroduplex and on the 3' side 
by the SL1 helix (Fig. 1 B). These results suggest that there are two potential components of 
a correct protein binding site: a dual UCUG single stranded sequence plus flanking base-
paired regions. 
In collaboration with Chris Leonard (Weeks Lab), I analyzed the Gag binding 
affinities for a set of MiDAS constructs intended to mimic or to disrupt each packaging 
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motif. Two parent constructs (cts) are the starting point for design of a comprehensive set of 
truncates. Each of the two starting constructs exists as a designed monomer, spans one of the 
tandem UCUG motifs, and includes flanking double stranded regions that mimic the MiDAS 
in the dimer state (cts 1 and 9, Table 1).  
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Construct 1 spans the first tandem UCUG sequence plus the flanking double stranded 
regions formed by PAL1, the 5-bp duplex and the long-range interaction in the flexible 
domain. Construct 9 mimics the structure of the second tandem UCUG repeat flanked by 
PAL2 and the lower part of SL1, as these structures exist in the dimer state (for both 
constructs, compare Table 1 with Fig. 1 B).  
To quantify the effect of the primary UCUG sequences and of the flanking structures 
on protein-RNA binding, we designed an instructive set of short RNA truncates in the 
context of each of the two parent constructs (Table 1) in which either the sequence (mts) or 
structure (cts) was compromised. Gag binds with a similar affinity to all these RNA 
constructs with equilibrium dissociation constants of 41-143 nM, indicative of a strong 
nonspecific component to binding. We, therefore, suppressed the effect of the nonspecific 
binding activity of Gag by adding a competitor RNA (tRNAPhe). Gag bound most tightly to 
the intact MiDAS RNA dimer, with a Kd of 15 nM. The presence of the competitor reveals a 
strong preferential binding by Gag as a function of the RNA construct used. However, 
addition of the competitor RNA does not significantly change the affinity of Gag binding to 
the RNA dimer (Kd = 23 nM).  
The two parent constructs (ct 1 and 9) had Gag binding affinities of 518 nM and 259 
nM, respectively. We first compromised nucleotides specifically bound by the zinc finger, by 
replacing them with adenosines. In PAL2 tandem motif (Table 1 B), we first replaced G4 
nucleotides with adenosines (mts 10-12). Eliminating both G4 nucleotides loosened binding 
by ~13× (mt 10, Kd = 3249 nM) compared to the parent construct (ct 9, Kd = 259 nM). To 
evaluate if the first U and the final G are equally important for Gag binding, we mutated the 
U1 in the UCUG sequences (mt 11). This mutant weakened binding only by 3× (Kd = 815 
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nM). A combination of U1 and G4 mutations drastically reduced Gag binding (mt 12, Kd 
~5944 nM), confirming that both U1 and G4 are important for high affinity Gag-RNA 
binding, with G4 contributing the most. A final construct in which flanking base-pairing 
structures were compromised (ct 13) had a Kd of 3510 nM, ~13.5× weaker than the starting 
construct.  
A second set of constructs were designed to compromise PAL1 tandem UCUG motif 
(mts 2-4, Table 1 A). Mutating the G4 in UCUG sequences weakened Gag binding by ~2× 
(Kd = 1154 and 869 nM for mts 2 and 4, respectively). Contrary to the PAL2 tandem motif, 
in PAL1 motif, U1 did not contribute to Gag binding (mt 3, Kd = 468 nM). Next, as our 
SHAPE reactivity profiles indicates possible nonspecific Gag binding sites at nts 220-223 
and 237-241 (Fig. 6 D), we mutated nts 222-224 and 237-239 (mt 5) to adenosines. 
Compensatory mutations (nts 278-280) were introduced to preserve formation of the 5-bp 
duplex. However, these mutations did not affect Gag binding. The binding contribution of the 
5-bp duplex or the long-range interaction helix was analyzed by successively eliminating 
each of these structures (cts 6 and 7, respectively). Eliminating the long-range interaction had 
the largest effect on Gag binding, decreasing the affinity by 4× (Kd = 2068 nM), while 
compromising the 5-bp duplex did not affect binding (Kd = 436 nM). Finally, we analyzed an 
RNA in which we prevented any 5' or 3' base pair formation (ct 8). In the absence of flanking 
duplexes, Gag binds 1.7× weaker to the first dual UCUG motif (Kd = 898 nM). These data 
indicate that although the constructs for PAL1 motif superficially resemble the PAL2 motif 
truncates Gag binds less discriminately to PAL1 tandem motif, probably because of the 
presence of additional nonspecific binding sites in this motif. Surprisingly, in PAL1 motif, 
the only element crucial for Gag binding is the long-range interaction duplex. In PAL2 motif, 
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eliminating either the UCUG sequences or the flanking structure drastically reduces protein 
binding.  
 
4.3 Discussion 
 In all normal retroviruses, the genomic RNA is packaged, perhaps exclusively, as a 
dimer. The packaging function is carried out exclusively by the viral Gag protein. Most 
importantly, the signal that is specifically recognized is a structural one. Recent work from 
several laboratories has revolved around a model in which the dimerization domain for 
MuLV and MuSV spans a relatively well-defined motif of approximately 170 nucleotides. 
This minimal dimerization active sequence (MiDAS)9 overlaps with regions that bind Gag 
and, thus, that direct packaging in vivo10.  
 
4.3.1 Direct analysis of the determinants of retroviral RNA genome packaging in 
virio. Although the localization and structure of the dimerization domain for gamma 
retroviruses is becoming well characterized, nearly nothing is known about specific protein 
binding sites, or the RNA minimal packaging motif. This limitation is mainly due to 
technical shortcomings: most in vitro studies that have analyzed Gag- and NC-RNA binding 
interactions have used short RNAs and, often, have employed binding conditions that are 
relatively far removed from those expected in vivo including unphysiological ionic 
conditions, millimolar-range protein and RNA concentrations. Results from these studies do 
not readily explain the exquisite binding specificity seen for retroviral RNA packaging. 
Moreover, mutations need to be introduced in RNAs to render them suitable for the intended 
analysis and it is typically difficult to deconvolute the effects of mutations on direct binding 
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versus indirect effect of altering RNA structure. 
 To investigate binding of Gag and NC to the retroviral RNA genome, we take a 
different approach. First, using SHAPE chemistry17,18, we examine protein-RNA interactions 
directly in authentic virions, less affected by in vitro conditions or extraction protocols. 
Second, we analyze protein binding sites in the context of genomic-length RNAs, unbiased 
by RNA mutations or truncations. Third, the SHAPE analysis provides not only a qualitative 
view of RNA protein binding sequences in an RNA, but also quantitative information 
regarding the extent to which each nucleotide becomes constrained by protein binding. 
 
 4.3.2 Genomic RNA dimerization is an RNA driven process. We mapped the 
structure of the dimerization domain for authentic MuLV genomic RNA with varying 
complements of its constituent proteins. The ex virio, AT-2 treated and in virio states 
contained no proteins, compromised NC zinc finger motifs, and the full set of all possible 
viral proteins, respectively. Although we clearly observe reproducible, and largely, local 
differences between these states, there are two dramatic conclusions from these analyses. 
First, removing the proteins from the dimerization domain clearly does not cause large 
changes to the overall architecture of the RNA (Fig. 3). Thus, protein components bind 
locally, but do not cause large scale structural rearrangements. Each of the major structures 
that contribute to the dimer state – PAL1, PAL2 and the SL1-SL2 stem loops – are clearly 
retained in all structural states (Fig. 3). This model is strongly reinforced by the analysis of in 
vitro dimers to which NC and Gag were added back as recombinant proteins. These 
reconstituted RNA dimer-protein complexes have almost the same nucleotide-resolution 
reactivity patterns as the ex virio state (Figs. 5 and 6). Second, the structure of the RNA as 
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mapped inside infectious virions is clearly highly similar to the structure of the RNA dimer 
generated from purified components in vitro. Thus, retroviral dimerization is an RNA-
centered process.  
Both the Gag polyprotein and NC, the main protein partner for the genomic RNA, 
bind to flexible regions near the 3' end of PAL1 and PAL2 (Fig. 4). Additionally, the NC has 
helix-melting properties5,16 and cause RNA conformational changes in the flexible domain, 
breaking the 5-bp helix and loosening the previously defined long-range interaction. In SL1, 
Gag and NC binding changes the orientation of the stem loop so that the GGAA bulge 
becomes less accessible to SHAPE reagents. A short region at the 3' end of PAL1 (nts 220-
225, Fig. 5 D) appears protected more by NC in virio and in vitro, but less by Gag. AT-2 
does not displace the NC from these nucleotides (Fig. 4 B), suggesting that this might be a 
potential nonspecific NC binding site. We infer that the NC domain of Gag is crucial for 
RNA dimer recognition and high affinity  binding, while other protein parts of Gag can play 
a role in narrowing the RNA binding specificity and/or different roles, for example in Gag-
Gag multimer assembly30,31.  
 
4.3.3 Minimal RNA packaging motifs. Within the overall architecture of the 
dimerization domain, we used protein protection factors (Fig. 6) to identify two primary sites 
that specifically bind Gag and NC. The same sites were identified independent of whether 
protein binding was assessed inside MuLV virions (Fig. 6 A,B) or using purified components 
(Figs. 6 C,D). Both sites span tandem UCUG sequences, each immediately 3' of PAL1 or 
PAL2. For both sites, SHAPE analysis indicates that the first U and the last G in the UCUG 
motifs become most highly constrained by protein binding. Strong binding by the NC domain 
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to guanosine residues is consistent with NMR studies showing that the zinc finger motif in 
NC specifically binds RNA via  a stacking interaction involving a tryptophan residue and 
hydrogen bonds with the protein backbone12. However, we additionally find that the first 
uridine in the UCUG motif plays a role contributor in the protein-RNA interaction. In each 
tandem motif, the UCUG sequences are separated by two nucleotides, generating the 
following consensus: UCUGURUCUG. Gag and NC interact with every fourth nucleotide in 
this motif. 
Both tandem UCUG consensus motifs in the MiDAS domain lie in similar, but non-
identical structural contexts. For both UCUG motifs, the structure context created by 
formation of the dimer state is essential for high affinity binding, although the roles of the 
two tandem UCUG sites are distinct. For PAL2 tandem motif, compromising either the 
UCUG sequences or the anchoring base-paired duplexes strongly compromises Gag binding 
(Table 1 B). In contrast, for PAL1 tandem motif, disrupting neither the UCUG sequences nor 
the flanking base-paired regions induces a dramatic reduction in Gag binding (Table 1 A). In 
this case, the most significant contributor to protein binding is the long-range interaction 
duplex, confirming the importance of this base-paired region in genome packaging. We can 
speculate that the PAL1 tandem motif is more important for Gag recognition and maybe the 
first to form and be bound by the protein. These data suggest that, for specific Gag-RNA 
recognition, it is not sufficient for the UCUG sequences simply to be intact, but these 
sequences must be presented in a specific local architecture, as a single-stranded region 
flanked by stable duplexes. In the MiDAS domain, this minimal packaging structure is only 
achieved after RNA dimerization, explaining how Gag discerns between packaging a 
nonfunctional monomer or a genomic RNA dimer.  
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In this work, I explored the use of RNA SHAPE chemistry to characterize specific 
protein-RNA interactions. SHAPE has multiple advantages over current in vitro methods: it 
can be used to analyze the RNA structure directly inside virions; allows the analysis of long 
RNA molecules; and can quantitatively estimate protein binding contributions of each 
nucleotide within a larger RNA binding site. SHAPE can potentially be used to characterize 
RNA structural recognition motifs and to assess the roles of RNA genomes in any RNA 
virus. 
 
4.4 Experimental procedures  
4.4.1 Virus preparation and SHAPE analysis of the ex virio and in vitro RNA 
dimers. Viral preparation, in virio SHAPE, RNA extraction, purification and quantification 
were performed by Julian W.J. Bess (HIV Drug Resistance Program, National Cancer 
Institute, Frederick, Maryland). Virus was obtained from NIH-3T3 cells (10 L) infected with 
MuLV (isolate SL658 DN) and was recovered from culture supernatants by single banding in 
sucrose gradients32. Virus pellets were resuspended in TNE [0.01 M Tris-HCl (pH 7.2), 0.1 
M NaCl, and 1 mM EDTA] at final concentration of 1000× relative to the starting culture 
volume and aliquots were stored at -70 °C. For analysis of the ex virio RNA, the genome was 
extracted from virions and subjected to SHAPE analysis as described (Chapter 3). The 331-nt 
in vitro MuLV RNA construct spanned the MiDAS region plus flanking 5' and 3' viral 
sequences of 46 and 115 nucleotides, respectively. The flanking 5' and 3' sequences allow 
SHAPE analysis of the entire MiDAS domain. 
 
 4.4.2 in virio RNA dimer extraction and quantification. For analysis of the MuLV 
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genomic RNA within virions, the viral concentrate (10 mL) was initially treated with 
subtilisin33 (total volume, 20 mL; 25 °C, overnight) to remove co-purifying membranous 
particles34. Subtilisin-treated virions were pelleted by ultracentrifugation (Beckman SW-41 
rotor; 37,000 rpm, 4 °C, 1.5 h) through a 20% (w/v) sucrose cushion in phosphate buffered 
saline (PBS). Pellets were resuspended in HFS buffer [2 mL; 50 mM HEPES (pH 8.0), 200 
mM NaCl, 0.1 mM EDTA, 10% (v/v) fetal bovine serum] and half volumes were treated with 
Aldrithiol-2 (AT-2, 2,2'-dithiodipyridine) in DMSO (2 µL; 0.5 mM) and or DMSO alone (2 
µL) and incubated overnight at 4 °C. Samples were pelleted through a 2-mL 20% (w/v) 
sucrose cushion (Beckman SW-60 rotor; 54,000 rpm, 1.5 h, 4°C) and pellets were 
resuspended in 1 mL of HFS buffer and divided into two aliquots. Samples were treated 
either with N-methyl isatoic anhydride (NMIA, 50 µL of 100 mM in DMSO) or neat DMSO. 
RNA was then recovered from all samples by lysis with proteinase K (190 µg/mL) in 50 mM 
Tris (pH 7.5), 1 mM EDTA, 10 mM DTT, 120 µg/mL glycogen, and 1% (w/v) SDS (25 °C, 
30 min), followed by extractions with equal volumes of phenol:chloroform:isoamyl alcohol 
(25:24:1, 10 times), and chloroform (2 times). RNA was precipitated in 70% ethanol with 0.3 
M sodium acetate and stored at -20 °C. RNA amounts were quantified by real-time reverse 
transcriptase PCR. 
 
 4.4.3 SHAPE analysis of in vitro MiDAS dimers in the presence of Gag and NC. 
Expression and purification of Gag and NC were performed by Sid A. Datta (AIDS Vaccine 
Program, Frederick, Maryland). The in vitro RNA construct (4 µL; 4 pmol) was denatured at 
95 °C for 3 min, snap cooled on ice for 2 min and treated with 3× dimerization buffer [2 µL; 
150 mM HEPES (pH 7.5), 600 mM potassium acetate (pH 7.5), 15 mM MgCl2]. The sample 
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was incubated at 60 °C for 30 min, then diluted with 25 µL 50 mM HEPES (pH 8). The 
resulting RNA dimer was equilibrated with either NC [5 µL; 200 µM (one protein per 1.3 
nts), 37 °C, 20 min] or Gag [0.5 µL; 40 µM (one protein per 66 nts)]. Control reactions were 
performed with NC buffer [50 mM HEPES (pH 8), 33.3 mM potassium acetate (pH 8),1 mM 
TCEP, 100 µM ZnCl2] and Gag buffer [20 mM Tris-HCl (pH 7.5), 0.5 M NaCl, 1 mM 
PMSF, 5 mM DTT]. Final concentrations of monovalent and divalent ions are the same for 
both proteins (40 mM NaCl or potassium acetate for Gag and NC, respectively, and 0.8 mM 
MgCl2); the very slightly different buffer compositions did not cause any detectable 
differences in RNA dimer structure (compare gray histograms in Figs. 5 A and B). 
 Protein-RNA dimer complexes (18 µL) were treated with 1-methyl-7-nitroisatoic 
anhydride (1M7, 2 µL; 2 mM in anhydrous DMSO)27 or with neat DMSO (37 °C, 2 min). 
Modified RNA (20 µL) was diluted in H2O (to 100 µL) and treated with EDTA (4.67 mM) 
and AT-2 (2 mM, 25 °C, 10 min). Samples were incubated with Proteinase K (0.35 mg/mL) 
in SDS (0.35%, 25 °C, 30 min), followed by phenol:chlorophorm:isoamyl alcohol extraction 
and ethanol precipitation. 
 
4.4.4 Analysis of NMIA- and 1M7-modified RNA. Sites of 2'-O-adduct formation 
were analyzed using fluorescently-labeled DNA primers and reverse transcriptase-mediated 
primer extension (Chapter 3). Raw sequencer traces were corrected for variation in dye 
intensities and signal decay and peak intensities were integrated using a custom software 
package (Chapter 3). Absolute SHAPE reactivities were normalized to a scale spanning 0 to 
~1.0, as described (Chapter 3). 
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 4.4.5 Binding affinities for MiDAS RNA constructs. Equilibrium dissociation 
constants were measured by Christopher W. Leonard (Weeks Lab, UNC) using a dual filter 
system35 in 50 mM HEPES (pH 7.7), 40 mM potassium acetate (pH 7.7), 0.8 mM MgCl2, 0.2 
mM DTT, 100 µg/mL BSA and 0.01% (v/v) Triton X-100. Reactions performed without 
competitor contained 40 pM [32P]-labeled RNA and 0.5-500 nM Gag. Reactions performed 
in the presence of competitor RNA contained 120 pM [32P]-labeled RNA and a 5000× molar 
excess of yeast tRNAPhe (Sigma-Aldrich). 
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